基本信息
罗成  男  博导  中国科学院上海药物研究所
电子邮件: cluo@simm.ac.cn
通信地址: 上海市祖冲之路555号药物发现与设计中心
邮政编码: 201203

招生信息

   
招生专业
100720-药物设计学
071023-计算生物学
070321-化学生物学
招生方向
药物设计学
计算生物学
结构生物学

教育背景

2005-09--2008-03 宾夕法尼亚大学Wistar研究所 博士后研究(计算生物学,结构生物学)
2001-09--2004-07 中国科学院上海药物研究所 有机化学博士学位
1998-09--2001-09 复旦大学化学系 物理化学(含化学物理)硕士学位
1990-09--1994-07 福州大学化学系 理学学士学位
学历
-- 研究生
学位
-- 博士

专利与奖励

   
专利成果
[1] 张翱, 罗成, 丁春勇, 张豪, 徐珩, 赵洪川, 蒋华良. 一类异喹啉衍生物及其制备和用途. CN: [[[CN111689975A]]], [[["2020-09-22"]]].
[2] 周兵, 罗成, 裴渊, 杨亚玺, 杜道海, 蒋华良, 乔刚. 三氮唑并嘧啶衍生物、其药物组合物及用途. CN115028631A, 2022-09-09.
[3] 张翱, 罗成, 丁春勇, 张豪, 徐珩, 李阳, 蒋华良. 一类雷公藤红素衍生物、其制备方法及用途. CN: CN112110977B, 2022-02-25.
[4] 游书力, 罗成, 刘喜佳, 张闪闪, 张豪, 顾庆. 一种丹酚酸B代谢物、中间体及其制备方法. CN: CN113999112A, 2022-02-01.
[5] 罗成, 奚晓东, 周兵, 朱孔凯, 毛建华, 刘静秋, 杨亚玺, 梅良和, 阮铮, 蒋昊, 奚闻达, 龙章彪, 肖兵, 黄建松, 蒋华良. 一种治疗血栓性疾病的化合物. CN: CN113968855A, 2022-01-25.
[6] 奚晓东, 罗成, 毛建华, 阮铮, 奚闻达, 龙章彪, 朱孔凯, 肖兵, 王韵, 黄建松, 蒋昊, 刘静秋, 蒋华良. 一种c-Src SH3 RT-loop作为靶点用于抗血栓. CN: CN113967257A, 2022-01-25.
[7] 奚晓东, 罗成, 毛建华, 阮铮, 奚闻达, 龙章彪, 朱孔凯, 肖兵, 黄建松, 蒋昊, 刘静秋, 杨亚玺, 周兵, 蒋华良. 一种干扰整合素β3/Src相互作用的化合物的用途. CN: CN113967210A, 2022-01-25.
[8] 郭跃伟, 李序文, 李松威, 吴祺豪, 姚励功, 罗成, 张豪. 吡喃酮类化合物的分离方法、吡喃酮类化合物及其用途. CN: CN113754644A, 2021-12-07.
[9] 张翱, 罗成, 李阳, 张豪, 徐珩, 丁春勇, 蒋华良. 一类氨基取代的雷公藤红素衍生物以及其制备方法和用途. CN: CN112094313A, 2020-12-18.
[10] 周兵, 罗成, 杨亚玺, 张元元, 杜道海, 蒋华良, 乔刚, 王新俊. 三氮唑并嘧啶、三氮唑并吡啶化合物及其组合物用于治疗PRC2 介导的疾病(日本). JP2020535215A, 2020-12-03.
[11] 罗成, 周兵, 陆文超, 王军, 李勇, 杨亚玺, 丁宏, 陶泓儒, 陈凯先, 蒋华良. 乙烯基磺酰胺或乙烯基酰胺类化合物及其制备方法和用途. CN: CN112010789A, 2020-12-01.
[12] 周兵, 罗成, 李子洲, 杨亚玺, 陈示洁, 丁宏, 蒋华良, 乔刚, 王新俊, 肖森豪. 溴结构域抑制剂化合物及其用途(美国). US20200354371A1, 2020-11-12.
[13] 周兵, 罗成, 杨亚玺, 张元元, 杜道海, 蒋华良, 乔刚, 王新俊. 三氮唑并嘧啶、三氮唑并吡啶化合物及其组合物用于治疗PRC2 介导的疾病(美国). US20200261459A1, 2020-08-20.
[14] 周兵, 罗成, 李子洲, 杨亚玺, 陈示洁, 鹿田, 肖森豪, 蒋华良, 陈超. 一类杂环化合物,其制备及用途. CN: CN111377934A, 2020-07-07.
[15] 李志裕, 罗成, 卞金磊, 赵曜, 丁宏, 田于成, 韩杰, 陈凯先. USP8抑制剂及其制备方法与应用. CN: CN111138358A, 2020-05-12.
[16] 罗成, 李林, 柳红, 陈丽敏, 李昕, 卢俊彦, 林岱宗, 付莉莉, 孔祥谦, 李国, 王雪琦, 梅长林, 蒋华良. 芬戈莫德或其盐在治疗囊肿性疾病中的用途. CN: CN105560219B, 2020-02-11.
[17] 周兵, 罗成, 蒋华良, 杨亚玺, 梅良和, 陆文超, 肖森豪, 陈示洁, 万世力, 乔刚, 张汝康. 组蛋白乙酰转移酶(HAT)抑制剂及其用途. CN: CN110386927A, 2019-10-29.
[18] 周兵, 罗成, 杨亚玺, 张元元, 杜道海, 蒋华良, 乔刚. 一种三氮唑并嘧啶衍生化合物、包含其的药物组合物及其用途. CN: CN110156787A, 2019-08-23.
[19] 周兵, 罗成, 李子洲, 杨亚玺, 陈示洁, 丁宏, 蒋华良, 乔刚, 王新俊, 肖森豪. 溴结构域抑制剂化合物及其用途. CN: CN110041333A, 2019-07-23.
[20] 李林, 罗成, 吴明, 戚娜, 胡骏驰, 吕佳怡, 李昕, 薛澄, 宋书伟, 付莉莉, 郁胜强, 梅长林. EZH2在制备预防或治疗多囊肾病药物中的应用. CN: CN109966479A, 2019-07-05.
[21] 周兵, 罗成, 杨亚玺, 张元元, 杜道海, 蒋华良, 乔刚, 王新俊. 三氮唑并嘧啶、三氮唑并吡啶化合物及其组合物用于治疗PRC2介导的疾病. CN: CN109843890A, 2019-06-04.
[22] 周兵, 罗成, 蒋华良, 杨亚玺, 梅良和, 陆文超, 肖森豪, 陈示洁, 万世力, 乔刚, 张汝康. 组蛋白乙酰转移酶(HAT)抑制剂及其用途(日本). JP2021506032, 2019-04-18.
[23] 周兵, 罗成, 杨亚玺, 张元元, 杜道海, 蒋华良, 乔刚. 三氮唑并嘧啶、三氮唑并吡啶化合物及其组合物用于治疗PRC2介导的疾病. CN: CN109575013A, 2019-04-05.
[24] 罗成, 姚志艺, 乔刚, 蒋华良, 周宇, 陈丽敏, 刘静秋, 丁宏. 五元杂环类化合物及其制备方法、药物组合物和用途. CN: CN109476650A, 2019-03-15.
[25] 罗成, 姚志艺, 乔刚, 蒋华良, 周宇, 陈丽敏, 刘静秋, 丁宏. 五元杂环类化合物及其制备方法、药物组合物和用途. CN: CN109476649A, 2019-03-15.
[26] 罗成, 姚志艺, 郑明月, 谢轶谦, 张元元, 邢婧, 乔刚, 梅良和, 蒋昊, 蒋华良. 一类稠合双环杂芳基或芳基化合物,及其用途. CN: CN109111426A, 2019-01-01.
[27] 罗成, 郑明月, 谢轶谦, 邢婧, 张元元, 蒋昊, 王晨, 陈凯先, 蒋华良. 8-羟基喹啉类药物或其盐在制备用于治疗与BRD4相关的疾病的药物中的应用. CN: CN109106715A, 2019-01-01.
[28] 罗成, 段文虎, 朱孔凯, 邵敬伟, 毛瑞风, 张元元, 蒋华良. 2-取代硫基乙酰胺类化合物及其制备方法和应用. CN: CN108689946A, 2018-10-23.
[29] 段文虎, 罗成, 邵敬伟, 朱孔凯, 张元元, 丁宏, 蒋华良. 一种具有PRMT5抑制活性的化合物及其制备和应用. CN: CN108570059A, 2018-09-25.
[30] 罗成, 杨亚玺, 乐立艳, 周兵, 杜娟娟, 张元元, 冯慧瑾, 李连春, 艾文, 陈智凤, 张碧东, 万伟, 林婷婷, 蒋华良. 1,4‑双取代‑1,2,3,6‑四氢吡啶类化合物、其制备方法、药物组合物及其应用. CN: CN107602446A, 2018-01-19.
[31] 罗成, 杨亚玺, 乐立艳, 周兵, 杜娟娟, 李连春, 张元元, 冯慧瑾, 艾文, 陈智凤, 张碧东, 林婷婷, 万伟, 蒋华良. 咯哌丁胺衍生物及其在制备治疗混合谱系白血病的药物中的应用. CN: CN107602445A, 2018-01-19.
[32] 杨财广, 刘江, 罗成, 郭中强, 巩守哲, 李家飞, 郑桐, 蒋华良. 2-亚胺-5-酮基-2,5-二氢-1-H-二吡啶并嘧啶类化合物. CN: CN107141287A, 2017-09-08.
[33] 陈畅, 罗成, 蒋华良, 李江美, 高振, 赵丹, 张伦峰, 乔新华. 肌醇磷脂4位激酶二型α亚型特异抑制剂PI-273的应用. CN: CN105326831A, 2016-02-17.
[34] 何川, 王晶, 蒋华良, 罗成, 柳红, 卢俊彦. 用于抑制人铜转运蛋白ATOX1和CCS的方法和组合物. US: CN105189474A, 2015-12-23.
[35] 罗成, 孔祥谦, 陈丽敏, 蒋翔锐, 杜道海, 卢俊彦, 刘静秋, 朱孔凯, 李连春, 丁宏, 陈凯先, 沈敬山, 蒋华良. 阿司咪唑、其盐或溶剂合物在制备预防和/或治疗恶性淋巴瘤的药物中的用途. CN: CN105078983A, 2015-11-25.
[36] 罗成, 李林, 柳红, 陈丽敏, 林岱宗, 李昕, 卢俊彦, 付莉莉, 赵飞, 李连春, 李国, 郁胜强, 梅长林, 蒋华良. 氨基醇类化合物、其制备方法、包含此类化合物的药物组合物及其用途. CN: CN105017034A, 2015-11-04.
[37] 杨财广, 罗成, 巩守哲, 刘洪川, 张瑞涵, 张婕, 蒋华良. 3,6-二取代1,2,4三唑3,4-b1,3,4噻二唑化合物及其用途. CN: CN104892639A, 2015-09-09.
[38] 杨财广, 罗成, 黄悦, 巩守哲, 李家飞, 蒋华良. 2-(取代苯氨基)苯甲酸及其酯类化合物制备FTO抑制剂的用途. CN: CN104069092A, 2014-10-01.
[39] 罗成, 柳红, 陈奕, 孔祥谦, 栗增, 冯恩光, 刘世恩, 陈先杰, 朱维良, 丁健, 蒋华良. 2-取代-5-苯基呋喃类化合物、其制备方法、药物组合物及其用途. CN: CN103509009A, 2014-01-15.
[40] 柳红, 耿美玉, 张登友, 艾菁, 罗成, 李淳朴, 陈曦, 梁中洁, 彭霞, 季寅淳, 蒋华良, 丁健, 陈凯先. 新型咪唑并1,2-a吡啶类化合物、其制备方法、包含此类化合物的药物组合物及其用途. CN: CN103214481A, 2013-07-24.
[41] 朱维良, 曾步斌, 王贺瑶, 闫桂蕊, 黄贤贵, 徐志建, 罗成, 张奇军, 王改红, 杨卓, 张小东, 李波, 徐炜均, 罗小民, 蒋华良, 陈凯先. 取代的酰肼类化合物及其制备方法、药物组合物和用途. CN: CN102775381A, 2012-11-14.
[42] 柳红, 耿美玉, 罗成, 张登友, 艾菁, 梁中洁, 王英, 蒋华良, 陈凯先. 新型胺基吡啶类化合物、其制备方法、包含此类化合物的药物组合物及其用途. CN: CN102718745A, 2012-10-10.
[43] 杨财广, 罗成, 叶飞, 陈报恩, 俞璐, 蒋华良. 大黄酸或大黄酸类化合物在制备治疗以FTO 为靶点的疾病的药物中的用途. CN: CN102697762A, 2012-10-03.
[44] 蒋华良, 沈旭, 柳红, 罗小民, 姚志艺, 陈静, 罗成, 周宇, 黎陈静, 左之利, 杜丽, 陈凯先, 乔·L.沙斯曼, 伊斯瑞尔·西尔曼, 泰伦·L.罗森伯瑞, 约瑟夫·L.约翰逊, 哈里·M.格林布莱特, 泰泽维亚·兹-本-莫德柴. 四氢喹啉类化合物、其制备方法及药物组合物. CN: CN101245062A, 2008-08-20.
[45] 朱维良, 李剑, 潘春木, 陈莉莉, 陈刚, 罗成, 左之利, 柳红, 罗小民, 陈凯先, 沈旭, 蒋华良. 3-烷氧取代-2,5,7-三取代苯并吡喃-4-酮类化合物及其制备方法和包含该类化合物的药物组合物. CN: CN1990479A, 2007-07-04.
[46] 朱维良, 潘春木, 陈莉莉, 沈旭, 陈刚, 罗成, 徐炜均, 罗小民, 柳红, 沈建华, 陈凯先, 蒋华良. 五羟黄酮-3-β-半乳糖苷的医药用途及其制剂. CN: CN1830449A, 2006-09-13.
[47] 蒋华良, 沈旭, 左建平, 白东鲁, 沈竞康, 沈建华, 罗小民, 桂春山, 罗成, 杨以阜, 郭虹霞, 陈晴, 刘学军, 王峰, 胡仲良, 杨勤刚, 蔡茂军, 张莉, 王昕, 庄贤韩, 南发俊, 杨一鸣. 一类喹喔啉衍生物及其制备方法和用途. CN: CN1590378A, 2005-03-09.

出版信息

   
发表论文
[1] Hao Jiang, Shijia Zu, Yu Lu, Zhongya Sun, Akejiang Adeerjiang, Qiao Guo, Huimin Zhang, Chen Dong, Qiqi Wu, Hong Ding, Daohai Du, Mingliang Wang, Chuanpeng Liu, Yong Tang, Zhongjie Liang, Cheng Luo. A RhoA structure with switch II flipped outward revealed the conformational dynamics of switch II region. JOURNAL OF STRUCTURAL BIOLOGY. 2023, 215(2): http://dx.doi.org/10.1016/j.jsb.2023.107942.
[2] Heng Xu, Hongfang Zhao, Chunyong Ding, Defang Jiang, Zijie Zhao, Yang Li, Xiaoyu Ding, Jing Gao, Hu Zhou, Cheng Luo, Guoqiang Chen, Ao Zhang, Ying Xu, Hao Zhang. Celastrol suppresses colorectal cancer via covalent targeting peroxiredoxin 1. SIGNAL TRANSDUCTION AND TARGETED THERAPY[J]. 2023, 8(1): 1-16, http://dx.doi.org/10.1038/s41392-022-01231-4.
[3] Xiao, Senhao, Guo, Siqi, Han, Jie, Sun, Yanli, Wang, Mingchen, Chen, Yantao, Fang, Xueyu, Yang, Feng, Mu, Yajuan, Zhang, Liang, Ding, Yiluan, Zhang, Naixia, Jiang, Hualiang, Chen, Kaixian, Zhao, Kehao, Luo, Cheng, Chen, Shijie. High-Throughput-Methyl-Reading (HTMR) assay: a solution based on nucleotide methyl-binding proteins enables large-scale screening for DNA/RNA methyltransferases and demethylases. NUCLEIC ACIDS RESEARCH[J]. 2022, 50(2): http://dx.doi.org/10.1093/nar/gkab989.
[4] Liu, Tonghai, Shi, Wenjia, Ding, Yiluan, Wu, Qiqi, Zhang, Bei, Zhang, Naixia, Wang, Mingliang, Du, Daohai, Zhang, Hao, Han, Bo, Guo, Dean, Zheng, Jie, Li, Qi, Luo, Cheng. (-)-Epigallocatechin Gallate is a Noncompetitive Inhibitor of NAD Kinase. ACS MEDICINAL CHEMISTRY LETTERS. 2022, [5] Lei, Yixuan, Fei, Panyu, Song, Bin, Shi, Wenjia, Luo, Cheng, Luo, Dahai, Li, Dan, Chen, Wei, Zheng, Jie. A loosened gating mechanism of RIG-I leads to autoimmune disorders. NUCLEIC ACIDS RESEARCH[J]. 2022, 50(10): 5850-5863, http://dx.doi.org/10.1093/nar/gkac361.
[6] Liao Liping, Dang Wenzhen, Lin Tingting, Yu Jinghua, Liu Tonghai, Li Wen, Xiao Senhao, Feng Lei, Huang Jing, Fu Rong, Li Jiacheng, Liu Liping, Wang Mingchen, Tao Hongru, Jiang Hualiang, Chen Kaixian, Diao Xingxing, Zhou Bing, Shen Xiaoyan, Luo Cheng. A potent PGK1 antagonist reveals PGK1 regulates the production of IL-1b and IL-6. ACTA PHARMACEUTICA SINICA B[J]. 2022, 12(11): 4180-4192, http://sciencechina.cn/gw.jsp?action=detail.jsp&internal_id=7343049&detailType=1.
[7] Huang, Jing, Wang, Xiaobo, Li, Bing, Shen, Shiyu, Wang, Ruina, Tao, Hongru, Hu, Junchi, Yu, Jin, Jiang, Hualiang, Chen, Kaixian, Luo, Cheng, Dang, Yongjun, Zhang, Yuanyuan. L-5-hydroxytryptophan promotes antitumor immunity by inhibiting PD-L1 inducible expression. JOURNAL FOR IMMUNOTHERAPY OF CANCER[J]. 2022, 10(6): https://doaj.org/article/417fb981fcae4ac29843cc2102fbc22e.
[8] Liping Liao, Wenzhen Dang, Tingting Lin, Jinghua Yu, Tonghai Liu, Wen Li, Senhao Xiao, Lei Feng, Jing Huang, Rong Fu, Jiacheng Li, Liping Liu, Mingchen Wang, Hongru Tao, Hualiang Jiang, Kaixian Chen, Xingxing Diao, Bing Zhou, Xiaoyan Shen, Cheng Luo. A potent PGK1 antagonist reveals PGK1 regulates the production of IL-1β and IL-6. ACTA PHARMACEUTICA SINICA B[J]. 2022, 12(11): 4180-4192, http://dx.doi.org/10.1016/j.apsb.2022.05.012.
[9] Mao, Jianhua, Zhu, Kongkai, Long, Zhangbiao, Zhang, Huimin, Xiao, Bing, Xi, Wenda, Wang, Yun, Huang, Jiansong, Liu, Jingqiu, Shi, Xiaofeng, Jiang, Hao, Lu, Tian, Wen, Yi, Zhang, Naixia, Meng, Qian, Zhou, Hu, Ruan, Zheng, Wang, Jin, Luo, Cheng, Xi, Xiaodong. Targeting the RT loop of Src SH3 in Platelets Prevents Thrombosis without Compromising Hemostasis. ADVANCED SCIENCE[J]. 2022, 9(7): http://dx.doi.org/10.1002/advs.202103228.
[10] Liu, Liping, Zhu, Rui, Li, Jiacheng, Pei, Yuan, Wang, Shuangshuang, Xu, Pan, Wang, Mingyu, Wen, Yu, Zhang, Hao, Du, Daohai, Ding, Hong, Jiang, Hualiang, Chen, Kaixian, Zhou, Bing, Yu, Lifang, Luo, Cheng. Computational and Structure-Based Development of High Potent Cell-Active Covalent Inhibitor Targeting the Peptidyl-Prolyl Isomerase NIMA-Interacting-1 (Pin1). JOURNAL OF MEDICINAL CHEMISTRY[J]. 2022, 65(3): 2174-2190, http://dx.doi.org/10.1021/acs.jmedchem.1c01686.
[11] Fu, Rong, Zu, ShiJia, Liu, YanJun, Li, JiaCheng, Dang, WenZhen, Liao, LiPing, Liu, LiPing, Chen, PanYu, Huang, HeMing, Wu, KangHui, Zhou, Bing, Pan, Qin, Luo, Cheng, Zhang, YuanYuan, Li, GuangMing. Selective bromodomain and extra-terminal bromodomain inhibitor inactivates macrophages and hepatic stellate cells to inhibit liver inflammation and fibrosis. BIOENGINEERED[J]. 2022, 13(4): 10914-10930, http://dx.doi.org/10.1080/21655979.2022.2066756.
[12] Yang, Fan, Sun, Rui, Hou, Zeng, Zhang, FangLin, Xiao, Yi, Yang, YunSong, Yang, ShaoYing, Xie, YiFan, Liu, YingYing, Luo, Cheng, Liu, GuangYu, Shao, ZhiMin, Li, DaQiang. HSP90 N-terminal inhibitors target oncoprotein MORC2 for autophagic degradation and suppress MORC2-driven breast cancer progression. CLINICAL AND TRANSLATIONAL MEDICINE[J]. 2022, 12(5): http://dx.doi.org/10.1002/ctm2.825.
[13] Wang, Yang, Yuan, Wenjie, Guo, Siqi, Li, Qiqi, Chen, Xiaomei, Li, Cheng, Liu, Qianying, Sun, Lei, Chen, Zhenguo, Yuan, Zhenghong, Luo, Cheng, Chen, Shijie, Tong, Shuping, Nassal, Michael, Wen, YuMei, Wang, YongXiang. A 33-residue peptide tag increases solubility and stability of Escherichia coli produced single-chain antibody fragments. NATURE COMMUNICATIONS[J]. 2022, 13(1): http://dx.doi.org/10.1038/s41467-022-32423-9.
[14] Xiaotong Diao, Fei Ye, Meina Zhang, Xintong Ren, Xiaoxu Tian, Jingping Lu, Xiangnan Sun, Zeng Hou, Xiaoyu Chen, Fengwei Li, Jingjing Zhuang, Hong Ding, Chao Peng, Fraydoon Rastinejad, Cheng Luo, Dalei Wu. Identification of oleoylethanolamide as an endogenous ligand for HIF-3α. NATURE COMMUNICATIONS[J]. 2022, 13(1): 1-12, https://doaj.org/article/3f12a7f39e5c4af89eb48bcbee994f58.
[15] Fan, Shijie, Yue, Liyan, Wan, Wei, Zhang, Yuanyuan, Zhang, Bidong, Otomo, Chinatsu, Li, Quanfu, Lin, Tingting, Hu, Junchi, Xu, Pan, Zhu, Mingrui, Tao, Hongru, Chen, Zhifeng, Li, Lianchun, Ding, Hong, Yao, Zhiyi, Lu, Junyan, Wen, Yi, Zhang, Naixia, Tan, Minjia, Chen, Kaixian, Xie, Yuli, Otomo, Takanori, Zhou, Bing, Jiang, Hualiang, Dang, Yongjun, Luo, Cheng. Inhibition of Autophagy by a Small Molecule through Covalent Modification of the LC3 Protein. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION[J]. 2021, 60(50): 26105-26114, http://apps.webofknowledge.com/CitedFullRecord.do?product=UA&colName=WOS&SID=5CCFccWmJJRAuMzNPjj&search_mode=CitedFullRecord&isickref=WOS:000714779000001.
[16] Xiong, Fengmin, Ding, Xiaoyu, Zhang, Hao, Luo, Xiaomin, Chen, Kaixian, Jiang, Hualiang, Luo, Cheng, Xu, Heng. Discovery of novel reversible monoacylglycerol lipase inhibitors via docking-based virtual screening. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS[J]. 2021, 41: http://dx.doi.org/10.1016/j.bmcl.2021.127986.
[17] Gao, Feng, Chen, Xiaoxu, Lu, Junyan, Hu, Shulei, Xu, Hui, Shi, Yuqiang, Feng, Mingshun, Ding, Jian, Liu, Hong, Luo, Cheng, Xie, Zuoquan, Wang, Jiang. Discovery of novel ceramide analogs with favorable pharmacokinetic properties and combination with AKT inhibitor against colon cancer. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY[J]. 2021, 215: http://dx.doi.org/10.1016/j.ejmech.2021.113274.
[18] Zhang, Youyi, Ye, Fei, Zhang, Tongtong, Lv, Shiyun, Zhou, Liping, Du, Daohai, Lin, He, Guo, Fei, Luo, Cheng, Zhu, Shujia. Structural basis of ketamine action on human NMDA receptors. NATURE[J]. 2021, 596(7871): 301-+, http://dx.doi.org/10.1038/s41586-021-03769-9.
[19] Zhang, Huimin, He, Jixiao, Hu, Guang, Zhu, Fei, Jiang, Hao, Gao, Jing, Zhou, Hu, Lin, Hua, Wang, Yingjuan, Chen, Kaixian, Meng, Fanwang, Hao, Minghong, Zhao, Kehao, Luo, Cheng, Liang, Zhongjie. Dynamics of Post-Translational Modification Inspires Drug Design in the Kinase Family. JOURNAL OF MEDICINAL CHEMISTRY[J]. 2021, 64(20): 15111-15125, http://dx.doi.org/10.1021/acs.jmedchem.1c01076.
[20] Song, Bin, Chen, Yun, Liu, Xin, Yuan, Fei, Tan, Eddie Yong Jun, Lei, Yixuan, Song, Ning, Han, Yinqi, Pascal, Bruce D, Griffin, Patrick R, Luo, Cheng, Wu, Bin, Luo, Dahai, Zheng, Jie. Ordered assembly of the cytosolic RNA-sensing MDA5-MAVS signaling complex via binding to unanchored K63-linked poly-ubiquitin chains. IMMUNITY[J]. 2021, 54(10): 2218-+, http://dx.doi.org/10.1016/j.immuni.2021.09.008.
[21] Ding, Hong, Pei, Yuan, Li, Yuanqing, Xu, Wen, Mei, Lianghe, Hou, Zeng, Guang, Yiman, Cao, Liyuan, Li, Peizhuo, Cao, Haijing, Bian, Jinlei, Chen, Kaixian, Luo, Cheng, Zhou, Bing, Zhang, Ting, Li, Zhiyu, Yang, Yaxi. Design, synthesis and biological evaluation of a novel spiro oxazolidinedione as potent p300/CBP HAT inhibitor for the treatment of ovarian cancer. BIOORGANIC & MEDICINAL CHEMISTRY[J]. 2021, 52: http://dx.doi.org/10.1016/j.bmc.2021.116512.
[22] Lin, Tingting, Li, Jiacheng, Liu, Liping, Li, Yuanqing, Jiang, Hualiang, Chen, Kaixian, Xu, Pan, Luo, Cheng, Zhou, Bing. Design, synthesis, and biological evaluation of 4-benzoylamino-1H-pyrazole-3-carboxamide derivatives as potent CDK2 inhibitors. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY[J]. 2021, 215: http://dx.doi.org/10.1016/j.ejmech.2021.113281.
[23] Zhou, Xiaoru, Li, Xiao, Liao, Liping, Han, Jie, Huang, Jing, Li, Jiacheng, Tao, Hongru, Fan, Shijie, Chen, Zhifeng, Li, Qi, Chen, Shijie, Ding, Hong, Yang, Yaxi, Zhou, Bing, Jiang, Hualiang, Chen, Kaixian, Zhang, Yuanyuan, Huang, Chuanxin, Luo, Cheng. P300/CBP inhibition sensitizes mantle cell lymphoma to PI3K delta inhibitor idelalisib. ACTA PHARMACOLOGICA SINICA[J]. 2021, https://www.webofscience.com/wos/woscc/full-record/WOS:000639768200001.
[24] Lu, Tian, Li, Yong, Lu, Wenchao, Spitters, Twgm, Fang, Xueyu, Wang, Jun, Cai, Simian, Gao, Jing, Zhou, Yanting, Duan, Zhe, Xiong, Huan, Liu, Liping, Li, Qi, Jiang, Hualiang, Chen, Kaixian, Zhou, Hu, Lin, Hua, Feng, Huijin, Zhou, Bing, Antos, Christopher L, Luo, Cheng. Discovery of a subtype-selective, covalent inhibitor against palmitoylation pocket of TEAD3. ACTA PHARMACEUTICA SINICA B[J]. 2021, 11(10): 3206-3219, http://dx.doi.org/10.1016/j.apsb.2021.04.015.
[25] Kong, Qidi, Pan, Wei, Xu, Heng, Xue, Yaru, Guo, Bin, Meng, Xin, Luo, Cheng, Wang, Ting, Zhang, Shuhua, Yang, Yushe. Design, Synthesis, and Biological Evaluation of Novel Pyrimido4,5-bindole Derivatives Against Gram-Negative Multidrug-Resistant Pathogens. JOURNAL OF MEDICINAL CHEMISTRY[J]. 2021, 64(12): 8644-8665, http://dx.doi.org/10.1021/acs.jmedchem.1c00621.
[26] Li, Wen, Liao, Liping, Song, Ning, Liu, Yanjun, Ding, Yiluan, Zhang, Yuanyuan, Zhou, Xiaoru, Sun, Zhongya, Xiao, Senhao, Wang, Hongbo, Lu, Jing, Zhang, Naixia, Jiang, Hualiang, Chen, Kaixian, Liu, Chuanpeng, Zheng, Jie, Zhao, Kehao, Luo, Cheng. Natural product 1,2,3,4,6-penta-O-galloyl-beta-D-glucopyranose is a reversible inhibitor of glyceraldehyde 3-phosphate dehydrogenase. ACTA PHARMACOLOGICA SINICA[J]. 2021, https://www.webofscience.com/wos/woscc/full-record/WOS:000639768200002.
[27] Du, Daohai, Xu, Dandan, Zhu, Licheng, Stazi, Giulia, Zwergel, Clemens, Liu, Yanli, Luo, Zhongyuan, Li, Yuanqing, Zhang, Yuanyuan, Zhu, Kongkai, Ding, Yiluan, Liu, Jingqiu, Fan, Shijie, Zhao, Kaiyan, Zhang, Naixia, Kong, Xiangqian, Jiang, Hualiang, Chen, Kaixian, Zhao, Kehao, Valente, Sergio, Min, Jinrong, Duan, Wenhu, Luo, Cheng. Structure-Guided Development of Small-Molecule PRC2 Inhibitors Targeting EZH2-EED Interaction. JOURNAL OF MEDICINAL CHEMISTRY[J]. 2021, 64(12): 8194-8207, http://dx.doi.org/10.1021/acs.jmedchem.0c02261.
[28] Wang, Zhen, Zhang, Hao, Chen, Baoen, Ouyang, Sisheng, Zheng, Tong, Zhou, Ran, Dong, Ze, Huang, Yue, Zhang, Tao, Jiang, Hualiang, Gan, Jianhua, Luo, Cheng, Yang, CaiGuang. A Peptide Binder of E3 Ligase Adaptor SPOP Disrupts Oncogenic SPOP-Protein Interactions in Kidney Cancer Cells. CHINESE JOURNAL OF CHEMISTRY[J]. 2021, 39(2): 274-280, http://dx.doi.org/10.1002/cjoc.202000462.
[29] Ding, Xiaoyu, Zhao, Zijie, Wu, Yue, Zhang, Hao, Chen, Kaixian, Luo, Cheng, Luo, Xiaomin, Xu, Heng. Identification of novel anti-inflammatory Nur77 modulators by virtual screening. BIOORGANIC CHEMISTRY[J]. 2021, 112: http://dx.doi.org/10.1016/j.bioorg.2021.104912.
[30] Huang, HeMing, Zhou, XiaoRu, Liu, YanJun, Fan, ShiJie, Liao, LiPing, Huang, Jing, Shi, CuiCui, Yu, Liang, Pen, JinJin, Luo, Cheng, Zhang, YuanYuan, Li, GuangMing. Histone deacetylase inhibitor givinostat alleviates liver fibrosis by regulating hepatic stellate cell activation. MOLECULAR MEDICINE REPORTS[J]. 2021, 23(5): https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7974418/.
[31] Luo, Zhongyuan, Du, Daohai, Liu, Yanjun, Lu, Tian, Liu, Liping, Jiang, Hualiang, Chen, Kaixian, Shan, Changliang, Luo, Cheng. Discovery and characterization of a novel glucose-6-phosphate dehydrogenase (G6PD) inhibitor via high-throughput screening. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS[J]. 2021, 40: http://dx.doi.org/10.1016/j.bmcl.2021.127905.
[32] Dong, Ze, Wang, Zhen, Guo, ZhongQiang, Gong, Shouzhe, Zhang, Tao, Liu, Jiang, Luo, Cheng, Jiang, Hualiang, Yang, CaiGuang. Structure-Activity Relationship of SPOP Inhibitors against Kidney Cancer. JOURNAL OF MEDICINAL CHEMISTRY[J]. 2020, 63(9): 4849-4866, https://www.webofscience.com/wos/woscc/full-record/WOS:000535279800029.
[33] Zuo, Yu, Xu, Heng, Chen, Zhifeng, Xiong, Fengmin, Zhang, Bei, Chen, Kaixian, Jiang, Hualiang, Luo, Cheng, Zhang, Hao. 17-AAG synergizes with Belinostat to exhibit a negative effect on the proliferation and invasion of MDA-MB-231 breast cancer cells. ONCOLOGY REPORTS[J]. 2020, 43(6): 1928-1944, [34] Hou, Zeng, Min, Wenjian, Zhang, Rukang, Niu, Ao, Li, Yuanqing, Cao, Liyuan, Han, Jie, Luo, Cheng, Yang, Peng, Ding, Hong. Lead discovery, chemical optimization, and biological evaluation studies of novel histone methyltransferase SET7 small-molecule inhibitors. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS[J]. 2020, 30(9): http://dx.doi.org/10.1016/j.bmcl.2020.127061.
[35] Li, Zizhou, Xiao, Senhao, Yang, Yaxi, Chen, Chao, Lu, Tian, Chen, Zhifeng, Jiang, Hualiang, Chen, Shijie, Luo, Cheng, Zhou, Bing. Discovery of 8-Methyl-pyrrolo1,2-apyrazin-1(2H)-one Derivatives as Highly Potent and Selective Bromodomain and Extra-Terminal (BET) Bromodomain Inhibitors. JOURNAL OF MEDICINAL CHEMISTRY[J]. 2020, 63(8): 3956-3975, [36] Lu, Tian, Lu, Wenchao, Luo, Cheng. A patent review of BRD4 inhibitors (2013-2019). EXPERT OPINION ON THERAPEUTIC PATENTS[J]. 2020, 30(1): 57-81, https://www.webofscience.com/wos/woscc/full-record/WOS:000502444100001.
[37] Sun, Zhongya, Zhang, Hao, Zhang, Yuanyuan, Liao, Liping, Zhou, Wen, Zhang, Fengcai, Lian, Fulin, Huang, Jing, Xu, Pan, Zhang, Rukang, Lu, Wenchao, Zhu, Mingrui, Tao, Hongru, Yang, Feng, Ding, Hong, Chen, Shijie, Yue, Liyan, Zhou, Bing, Zhang, Naixia, Tan, Minjia, Jiang, Hualiang, Chen, Kaixian, Liu, Bo, Liu, Chuanpeng, Dang, Yongjun, Luo, Cheng. Covalent Inhibitors Allosterically Block the Activation of Rho Family Proteins and Suppress Cancer Cell Invasion. ADVANCED SCIENCE[J]. 2020, 7(14): https://doaj.org/article/2e4dbc3d2ae14c49977b0ef0da5f68ca.
[38] Li, Zhiqiang, Li, Xinzhi, Su, MingBo, Gao, LiXin, Zhou, YuBo, Yuan, Bingchuan, Lyu, Xilin, Yan, Ziqin, Hu, Chujiao, Zhang, Hao, Luo, Cheng, Chen, Zheng, Li, Jia, Zhao, Yujun. Discovery of a Potent and Selective NF-kappa B-Inducing Kinase (NIK) Inhibitor That Has Anti-inflammatory Effects in Vitro and in Vivo. JOURNAL OF MEDICINAL CHEMISTRY[J]. 2020, 63(8): 4388-4407, https://www.webofscience.com/wos/woscc/full-record/WOS:000529170200035.
[39] Min, Wenjian, Hou, Zeng, Zhang, Fang, Xie, Shengnan, Yuan, Kai, Dong, Haojie, Wang, Liping, Qi, Lianwen, Luo, Cheng, Ding, Hong, Yang, Peng. Computational discovery and biological evaluation of novel inhibitors targeting histone-lysine N-methyltransferase SET7. BIOORGANIC & MEDICINAL CHEMISTRY[J]. 2020, 28(7): http://dx.doi.org/10.1016/j.bmc.2020.115372.
[40] Hait, Nitai C, Maiti, Aparna, Xu, Pan, Qi, Qianya, Kawaguchi, Tsutomu, Okano, Maiko, Takabe, Kazuaki, Yan, Li, Luo, Cheng. Regulation of hypoxia-inducible factor functions in the nucleus by sphingosine-1-phosphate. FASEB JOURNAL[J]. 2020, 34(3): 4293-4310, https://www.webofscience.com/wos/woscc/full-record/WOS:000511114000001.
[41] Xu, Heng, Tang, Zhengkuan, Zuo, Yu, Xiong, Fengmin, Chen, Kaixian, Jiang, Hualiang, Luo, Cheng, Zhang, Hao. Molecular dynamics simulation revealed the intrinsic conformational change of cellular inhibitor of apoptosis protein-1. JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS[J]. 2020, 38(4): 975-984, http://dx.doi.org/10.1080/07391102.2019.1591303.
[42] Chen, Yu, Bi, Xiaoyang, Zhang, Fengcai, Sun, Zhongya, Xu, Pan, Jiang, Hao, Lu, Wenchao, Lu, Tian, Ding, Hong, Zhang, Naixia, Jiang, Hualiang, Chen, Kaixian, Zhou, Bing, Luo, Cheng. Design, synthesis, and biological evaluation of tetrahydroquinolin derivatives as potent inhibitors of CBP bromodomain. BIOORGANIC CHEMISTRY[J]. 2020, 101: http://dx.doi.org/10.1016/j.bioorg.2020.103991.
[43] Han, Jie, Tian, Yucheng, Yu, Liang, Zhang, Qilin, Xu, Xi, Zhang, Yichao, Wang, Jubo, Ma, Zengyi, Bian, Jinlei, Luo, Cheng, Jiang, Hualiang, Chen, Kaixian, Zhao, Yao, Li, Zhiyu, Ding, Hong. Discovery of novel USP8 inhibitors via Ubiquitin-Rho-110 fluorometric assay based high throughput screening. BIOORGANIC CHEMISTRY[J]. 2020, 101: http://dx.doi.org/10.1016/j.bioorg.2020.103962.
[44] Mingcheng Yu, Feng Yang, Xiaoyu Ding, Nannan Sun, Zhengyuan Jiang, Yafei Huang, Yurong Yan, Chen Zhu, Qiong Xie, Zhifeng Chen, Siqi Guo, Hualiang Jiang, Kaixian Chen, Cheng Luo, Xiaomin Luo, Shijie Chen, Yonghui Wang. Crystallography-guided discovery of carbazole-based retinoic acid-related orphan receptor gamma-t (RORγt) modulators: insights into different protein behaviors with "short" and "long" inverse agonists. ACTA PHARMACOLOGICA SINICA. 2020, 42(9): 1524-1534, https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8379218/.
[45] Zhang Fengcai, Sun Zhongya, Liao Liping, Zuo Yu, Zhang Dan, Wang Jun, Chen Yantao, Xiao Senhao, Jiang Hao, Lu Tian, Xu Pan, Yue Liyan, Du Daohai, Zhang Hao, Liu Chuanpeng, Luo Cheng. Discovery of novel CBP bromodomain inhibitors through TR-FRET-based high-throughput screening. ACTA PHARMACOLOGICA SINICA[J]. 2020, 41(2): 285-291, http://lib.cqvip.com/Qikan/Article/Detail?id=7101290880.
[46] Yang, Yaxi, Zhang, Rukang, Li, Zhaojun, Mei, Lianghe, Wan, Shili, Ding, Hong, Chen, Zhifeng, Xing, Jing, Feng, Huijin, Han, Jie, Jiang, Hualiang, Zheng, Mingyue, Luo, Cheng, Zhou, Bing. Discovery of Highly Potent, Selective, and Orally Efficacious p300/CBP Histone Acetyltransferases Inhibitors. JOURNAL OF MEDICINAL CHEMISTRY[J]. 2020, 63(3): 1337-1360, http://dx.doi.org/10.1021/acs.jmedchem.9b01721.
[47] Ye, Fei, Huang, Jing, Wang, Hongbo, Luo, Cheng, Zhao, Kehao. Targeting epigenetic machinery: Emerging novel allosteric inhibitors. PHARMACOLOGY & THERAPEUTICS[J]. 2019, 204: http://dx.doi.org/10.1016/j.pharmthera.2019.107406.
[48] Ye, Fei, Huang, Jing, Wang, Hongbo, Luo, Cheng, Zhao, Kehao. Targeting epigenetic machinery: Emerging novel allosteric inhibitors. PHARMACOLOGY & THERAPEUTICSnull. 2019, 204: http://dx.doi.org/10.1016/j.pharmthera.2019.107406.
[49] Shi, Chenghui, Zhang, Yinyong, Wang, Ting, Lu, Wenchao, Zhang, Shuhua, Guo, Bin, Chen, Qian, Luo, Cheng, Zhou, Xianli, Yang, Yushe. Design, Synthesis, and Biological Evaluation of Novel DNA Gyrase-Inhibiting Spiropyrimidinetriones as Potent Antibiotics for Treatment of Infections Caused by Multidrug-Resistant Gram-Positive Bacteria. JOURNAL OF MEDICINAL CHEMISTRY[J]. 2019, 62(6): 2950-2973, [50] Chen, Deheng, Lu, Tian, Yan, Ziqin, Lu, Wenchao, Lyu, Xilin, Xu, Biling, Jiang, Hualiang, Chen, Kaixian, Luo, Cheng, Zhao, Yujun. Discovery, structural insight, and bioactivities of BY27 as a selective inhibitor of the second bromodomains of BET proteins. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY[J]. 2019, 182: http://dx.doi.org/10.1016/j.ejmech.2019.111633.
[51] Fu, Tianran, Liu, Liping, Yang, QingLin, Wang, Yuxin, Xu, Pan, Zhang, Lin, Liu, Shien, Dai, Qing, Ji, Quanjiang, Xu, GuoLiang, He, Chuan, Luo, Cheng, Zhang, Liang. Thymine DNA glycosylase recognizes the geometry alteration of minor grooves induced by 5-formylcytosine and 5-carboxylcytosine. CHEMICAL SCIENCE[J]. 2019, 10(31): 7407-7417, [52] Xing, Jing, Zhang, Rukang, Jiang, Xiangrui, Hu, Tianwen, Wang, Xinjun, Qiao, Gang, Wang, Junjian, Yang, Fengling, Luo, Xiaomin, Chen, Kaixian, Shen, Jingshan, Luo, Cheng, Jiang, Hualiang, Zheng, Mingyue. Rational design of 5-((1H-imidazol-1-yl)methyl)quinolin-8-ol derivatives as novel bromodomain-containing protein 4 inhibitors. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY[J]. 2019, 163: 281-294, http://dx.doi.org/10.1016/j.ejmech.2018.11.018.
[53] Zhang, Dan, Han, Jie, Lu, Wenchao, Lian, Fulin, Wang, Jun, Lu, Tian, Tao, Hongru, Xiao, Senhao, Zhang, Fengcai, Liu, YuChih, Liu, Rongfeng, Zhang, Naixia, Jiang, Hualiang, Chen, Kaixian, Zhao, Chunshen, Luo, Cheng. Discovery of alkoxy benzamide derivatives as novel BPTF bromodomain inhibitors via structure-based virtual screening. BIOORGANIC CHEMISTRY[J]. 2019, 86: 494-500, http://dx.doi.org/10.1016/j.bioorg.2019.01.035.
[54] Lu, Wenchao, Wang, Jun, Li, Yong, Tao, Hongru, Xiong, Huan, Lian, Fulin, Gao, Jing, Ma, Hongna, Lu, Tian, Zhang, Dan, Ye, Xiaoqing, Ding, Hong, Yue, Liyan, Zhang, Yuanyuan, Tang, Huanyu, Zhang, Naixia, Yang, Yaxi, Jiang, Hualiang, Chen, Kaixian, Zhou, Bing, Luo, Cheng. Discovery and biological evaluation of vinylsulfonamide derivatives as highly potent, covalent TEAD autopalmitoylation inhibitors. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY[J]. 2019, 184: http://dx.doi.org/10.1016/j.ejmech.2019.111767.
[55] 彭金金, 黄鹤鸣, 刘彦君, 石翠翠, 范建高, 张元元, 罗成, 李光明. 组蛋白乙酰化酶抑制剂(DCH36_06)对小鼠急性肝损伤的保护作用及机制研究. 肝脏[J]. 2019, 24(10): 1125-1128, http://lib.cqvip.com/Qikan/Article/Detail?id=7003089613.
[56] Peng, Jinjin, Li, Jiacheng, Huang, Jing, Xu, Pan, Huang, Heming, Liu, Yanjun, Yu, Liang, Yang, Yaxi, Zhou, Bing, Jiang, Hualiang, Chen, Kaixian, Dang, Yongjun, Zhang, Yuanyuan, Luo, Cheng, Li, Guangming. p300/CBP inhibitor A-485 alleviates acute liver injury by regulating macrophage activation and polarization. THERANOSTICS[J]. 2019, 9(26): 8344-8361, http://dx.doi.org/10.7150/thno.30707.
[57] Tao, Hongru, Wang, Jun, Lu, Wenchao, Zhang, Rukang, Xie, Yiqian, Liu, YuChih, Liu, Rongfeng, Yue, Liyan, Chen, Kaixian, Jiang, Hualiang, Zhang, Yuanyuan, Xu, Xiaohui, Luo, Cheng. Discovery of trisubstituted nicotinonitrile derivatives as novel human GCN5 inhibitors through AlphaScreen-based high throughput screening. RSC ADVANCES[J]. 2019, 9(9): 4917-4924, http://www.corc.org.cn/handle/1471x/2162221.
[58] Chen, Shi, Wiewiora, Rafal P, Meng, Fanwang, Babault, Nicolas, Ma, Anqi, Yu, Wenyu, Qian, Kun, Hu, Hao, Zou, Hua, Wang, Junyi, Fan, Shijie, Blum, Gil, PittellaSilva, Fabio, Beauchamp, Kyle A, Tempel, Wolfram, Jiang, Hualiang, Chen, Kaixian, Skene, Robert J, Zheng, Yujun George, Brown, Peter J, Jin, Jian, Luo, Cheng, Chodera, John D, Luo, Minkui. The dynamic conformational landscape of the protein methyltransferase SETD8. ELIFE[J]. 2019, 8: http://gooa.las.ac.cn/external/index?type=-1&pid=1500244.
[59] Ye, Fei, Kong, Xiangqian, Zhang, Hao, Liu, Yan, Shao, Zhiyuan, Jin, Jia, Cai, Yi, Zhang, Rukang, Li, Linjuan, Zhang, Uang W, Liu, YuChih, Zhang, Chenhua, Xie, Wenbing, Yu, Kunqian, Ding, Hong, Zhao, Kehao, Chen, Shijie, Jiang, Hualiang, Baylin, Stephen B, Luo, Cheng. Biochemical Studies and Molecular Dynamic Simulations Reveal the Molecular Basis of Conformational Changes in DNA Methyltransferase-1. ACS CHEMICAL BIOLOGY[J]. 2018, 13(3): 772-781, https://www.webofscience.com/wos/woscc/full-record/WOS:000428003000035.
[60] Zhang, Rukang, Wang, Jiang, Zhao, Liang, Liu, Shien, Du, Daohai, Ding, Hong, Chen, Shijie, Yue, Liyan, Liu, YuChih, Zhang, Chenhua, Liu, Hong, Luo, Cheng. Identification of novel inhibitors of histone acetyltransferase hMOF through high throughput screening. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY[J]. 2018, 157: 867-876, http://dx.doi.org/10.1016/j.ejmech.2018.08.026.
[61] Tian LU, Jun-chi HU, Wen-chao LU, Jie HAN, Hong DING, Hao JIANG, Yuan-yuan ZHANG, Li-yan YUE, Shi-jie CHEN, Hua-liang JIANG, Kai-xian CHEN, Hui-fang CHAI, Cheng LUO. Identification of small molecule inhibitors targeting the SMARCA2 bromodomain from a high-throughput screening assay. 中国药理学报:英文版[J]. 2018, 39(9): 1544-1552, http://lib.cqvip.com/Qikan/Article/Detail?id=676403272.
[62] Fan, Shijie, Chen, Yu, Luo, Cheng, Meng, Fanwang. Machine Learning Methods in Precision Medicine Targeting Epigenetic Diseases. CURRENT PHARMACEUTICAL DESIGN[J]. 2018, 24(34): 3998-4006, http://dx.doi.org/10.2174/1381612824666181112114228.
[63] Lu, Wenchao, Zhang, Rukang, Jiang, Hao, Zhang, Huimin, Luo, Cheng. Computer-Aided Drug Design in Epigenetics. FRONTIERS IN CHEMISTRY[J]. 2018, 6: https://doaj.org/article/0c41d1298a0a495492231cd0ab6b7c34.
[64] Pengfei Zhou, Yuru Liang, Hao Zhang, Hao Jiang, Kechang Feng, Pan Xu, Jie Wang, Xiaoming Wang, Kuiling Ding, Cheng Luo, Mingming Liu, Yang Wang. Design, synthesis, biological evaluation and cocrystal structures with tubulin of chiral β-lactam bridged combretastatin A-4 analogues as potent antitumor agents. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY. 2018, 144: 817-842, http://dx.doi.org/10.1016/j.ejmech.2017.12.004.
[65] Zhang, JinBao, Chang, Shenghai, Xu, Pan, Miao, Miao, Wu, Hangjun, Zhang, Youyi, Zhang, Tongtong, Wang, Han, Zhang, Jilin, Xie, Chun, Song, Nan, Luo, Cheng, Zhang, Xing, Zhu, Shujia. Structural Basis of the Proton Sensitivity of Human GluN1-GluN2A NMDA Receptors. CELL REPORTS[J]. 2018, 25(13): 3582-+, http://dx.doi.org/10.1016/j.celrep.2018.11.071.
[66] Zhang, Li, Chen, Yantao, Liu, Na, Li, Linjuan, Xiao, Senhao, Li, Xiaoliu, Chen, Kaixian, Luo, Cheng, Chen, Shijie, Chen, Hua. Design, synthesis and anti leukemia cells proliferation activities of pyrimidylaminoquinoline derivatives as DOT1L inhibitors. BIOORGANIC CHEMISTRY[J]. 2018, 80: 649-654, http://dx.doi.org/10.1016/j.bioorg.2018.07.022.
[67] Wang, Chen, Xu, Pan, Zhang, Luyu, Huang, Jing, Zhu, Kongkai, Luo, Cheng. Current Strategies and Applications for Precision Drug Design. FRONTIERS IN PHARMACOLOGY[J]. 2018, 9: https://doaj.org/article/5702e8aa9ca740d88cdb5bbdab4ce87f.
[68] Lu, Tian, Hu, Junchi, Lu, Wenchao, Han, Jie, Ding, Hong, Jiang, Hao, Zhang, Yuanyuan, Yue, Liyan, Chen, Shijie, Jiang, Hualiang, Chen, Kaixian, Chai, Huifang, Luo, Cheng. Identification of small molecule inhibitors targeting the SMARCA2 bromodomain from a high-throughput screening assay. ACTA PHARMACOLOGICA SINICA[J]. 2018, 39(9): 1544-1552, http://lib.cqvip.com/Qikan/Article/Detail?id=676403272.
[69] ChenHong Ding, Chuan Yin, ShiJie Chen, LiangZhi Wen, Kai Ding, ShuJuan Lei, JinPei Liu, Jian Wang, Kaixian Chen, Hualiang Jiang, Xin Zhang, Cheng Luo, WeiFen Xie. The HNF1α-regulated lncRNA HNF1A-AS1 reverses the malignancy of hepatocellular carcinoma by enhancing the phosphatase activity of SHP-1. MOLECULAR CANCER[J]. 2018, 17(1): 1-14, https://doaj.org/article/fb9a88e56d2a4b44a8ad56f9a473942e.
[70] Xiong, Huan, Han, Jie, Wang, Jun, Lu, Wenchao, Wang, Chen, Chen, Yu, Lian, Fulin, Zhang, Naixia, Liu, YuChih, Zhang, Chenhua, Ding, Hong, Jiang, Hualiang, Lu, Wencong, Luo, Cheng, Zhou, Bing. Discovery of 1,8-acridinedione derivatives as novel GCN5 inhibitors via high throughput screening. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY[J]. 2018, 151: 740-751, http://www.corc.org.cn/handle/1471x/2181016.
[71] Lu, Wenchao, Xiong, Huan, Chen, Yu, Wang, Chen, Zhang, Hao, Xu, Pan, Han, Jie, Xiao, Senhao, Ding, Hong, Chen, Zhifeng, Lu, Tian, Wang, Jun, Zhang, Yuanyuan, Yue, Liyan, Liu, YuChih, Zhang, Chenhua, Yang, Yaxi, Jiang, Hualiang, Chen, Kaixian, Zhou, Bing, Luo, Cheng. Discovery and biological evaluation of thiobarbituric derivatives as potent p300/CBP inhibitors. BIOORGANIC & MEDICINAL CHEMISTRY[J]. 2018, 26(20): 5397-5407, http://dx.doi.org/10.1016/j.bmc.2018.07.048.
[72] Zhu, Kongkai, Jiang, ChengShi, Hu, Junchi, Liu, Xigong, Yan, Xue, Tao, Hongrui, Luo, Cheng, Zhang, Hua. Interaction assessments of the first S-adenosylmethionine competitive inhibitor and the essential interacting partner methylosome protein 50 with protein arginine methyltransferase 5 by combined computational methods. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS[J]. 2018, 495(1): 721-727, http://dx.doi.org/10.1016/j.bbrc.2017.11.089.
[73] Chen, Wei, Zhang, Hao, Chen, Zhifeng, Jiang, Hao, Liao, Liping, Fan, Shijie, Xing, Jing, Xie, Yiqian, Chen, Shijie, Ding, Hong, Chen, Kaixian, Jiang, Hualiang, Luo, Cheng, Zheng, Mingyue, Yao, Zhiyi, Huang, Yiran, Zhang, Yuanyuan. Development and evaluation of a novel series of Nitroxoline-derived BET inhibitors with antitumor activity in renal cell carcinoma. ONCOGENESIS[J]. 2018, 7(11): https://doaj.org/article/40ae4206aab143f7a27581e0efafc2a0.
[74] Liang, Zhongjie, Hu, Junchi, Yan, Wenying, Jiang, Hualiang, Hu, Guang, Luo, Cheng. Deciphering the role of dimer interface in intrinsic dynamics and allosteric pathways underlying the functional transformation of DNMT3A. BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS[J]. 2018, 1862(7): 1667-1679, http://dx.doi.org/10.1016/j.bbagen.2018.04.015.
[75] Zhou, Pengfei, Liang, Yuru, Zhang, Hao, Jiang, Hao, Feng, Kechang, Xu, Pan, Wang, Jie, Wang, Xiaoming, Ding, Kuiling, Luo, Cheng, Liu, Mingming, Wang, Yang. Design, synthesis, biological evaluation and cocrystal structures with tubulin of chiral beta-lactam bridged combretastatin A-4 analogues as potent antitumor agents. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY[J]. 2018, 144: 817-842, https://www.webofscience.com/wos/woscc/full-record/WOS:000425198100062.
[76] Song, Yakai, Li, Linjuan, Chen, Yantao, Liu, Jingqiu, Xiao, Senhao, Lian, Fulin, Zhang, Naixia, Ding, Hong, Zhang, Yuanyuan, Chen, Kaixian, Jiang, Hualiang, Zhang, Chenhua, Liu, YuChih, Chen, Shijie, Luo, Cheng. Discovery of potent DOT1L inhibitors by AlphaLISA based High Throughput Screening assay. BIOORGANIC & MEDICINAL CHEMISTRY[J]. 2018, 26(8): 1751-1758, http://dx.doi.org/10.1016/j.bmc.2018.02.020.
[77] Jianhua Chen, Xuemin Jian, Siyu Deng, Zengyi Ma, Xuefei Shou, Yue Shen, Qilin Zhang, Zhijian Song, Zhiqiang Li, Hong Peng, Cheng Peng, Min Chen, Cheng Luo, Dan Zhao, Zhao Ye, Ming Shen, Yichao Zhang, Juan Zhou, Aamir Fahira, Yongfei Wang, Shiqi Li, Zhaoyun Zhang, Hongying Ye, Yiming Li, Jiawei Shen, Hong Chen, Feng Tang, Zhenwei Yao, Zhifeng Shi, Chunjui Chen, Lu Xie, Ye Wang, Chaowei Fu, Ying Mao, Liangfu Zhou, Daming Gao, Hai Yan, Yao Zhao, Chuanxin Huang, Yongyong Shi. Identification of recurrent USP48 and BRAF mutations in Cushing's disease. NATURE COMMUNICATIONS[J]. 2018, 9(1): http://202.127.25.143/handle/331003/3419.
[78] 孙冰洁, 陈示洁, 邓龙飞, 丁晨虹, 陈斐, 罗成, 谢渭芬, 张新. 基于报告基因系统的肝细胞核因子4活性检测体系的建立. 第二军医大学学报[J]. 2017, 38(9): 1112-, http://lib.cqvip.com/Qikan/Article/Detail?id=673335624.
[79] Ye, Yan, Zhang, Bidong, Mao, Ruifeng, Zhang, Chenhua, Wang, Yulan, Xing, Jing, Liu, YuChih, Luo, Xiaomin, Ding, Hong, Yang, Yaxi, Zhou, Bing, Jiang, Hualiang, Chen, Kaixian, Luo, Cheng, Zheng, Mingyue. Discovery and optimization of selective inhibitors of protein arginine methyltransferase 5 by docking-based virtual screening. ORGANIC & BIOMOLECULAR CHEMISTRY[J]. 2017, 15(17): 3648-3661, https://www.webofscience.com/wos/woscc/full-record/WOS:000400868000015.
[80] Feng, Bing, Zhou, Fangyuan, Lu, Wenchao, Wang, Dangge, Wang, Tingting, Luo, Cheng, Wang, Hao, Li, Yaping, Yu, Haijun. Phospholipid-mimic oxaliplatin prodrug liposome for treatment of the metastatic triple negative breast cancer. BIOMATERIALS SCIENCE[J]. 2017, 5(8): 1522-1525, http://dx.doi.org/10.1039/c7bm00058h.
[81] Li, Jiangmei, Gao, Zhen, Zhao, Dan, Zhang, Lunfeng, Qiao, Xinhua, Zhao, Yingying, Ding, Hong, Zhang, Panpan, Lu, Junyan, Liu, Jia, Jiang, Hualiang, Luo, Cheng, Chen, Chang. PI-273, a Substrate-Competitive, Specific Small-Molecule Inhibitor of PI4KII alpha, Inhibits the Growth of Breast Cancer Cells. CANCER RESEARCH[J]. 2017, 77(22): 6253-6266, https://www.webofscience.com/wos/woscc/full-record/WOS:000415107900019.
[82] Wang, Chen, Jiang, Hao, Jin, Jia, Xie, Yiqian, Chen, Zhifeng, Zhang, Hao, Lian, Fulin, Liu, YuChih, Zhang, Chenhua, Ding, Hong, Chen, Shijie, Zhang, Naixia, Zhang, Yuanyuan, Jiang, Hualiang, Chen, Kaixian, Ye, Fei, Yao, Zhiyi, Luo, Cheng. Development of Potent Type I Protein Arginine Methyltransferase (PRMT) Inhibitors of Leukemia Cell Proliferation. JOURNAL OF MEDICINAL CHEMISTRY[J]. 2017, 60(21): 8888-8905, http://dx.doi.org/10.1021/acs.jmedchem.7b01134.
[83] Xing, Jing, Lu, Wenchao, Liu, Rongfeng, Wang, Yulan, Xie, Yiqian, Zhang, Hao, Shi, Zhe, Jiang, Hao, Liu, YuChih, Chen, Kaixian, Jiang, Hualiang, Luo, Cheng, Zheng, Mingyue. Machine-Learning-Assisted Approach for Discovering Novel Inhibitors Targeting Bromodomain-Containing Protein 4. JOURNAL OF CHEMICAL INFORMATION AND MODELING[J]. 2017, 57(7): 1677-1690, http://dx.doi.org/10.1021/acs.jcim.7b00098.
[84] Wang Yulan, Li Linjuan, Zhang Bidong, Xing Jing, Chen Shijie, Wan Wei, Song Yakai, Jiang Hao, Jiang Hualiang, Luo Cheng, Zheng Mingyue. Discovery of Novel Disruptor of Silencing Telomeric 1-Like (DOT1L) Inhibitors using a Target-Specific Scoring Function for the (S)-Adenosyl-l-methionine (SAM)-Dependent Methyltransferase Family.. JOURNAL OF MEDICINAL CHEMISTRY. 2017, [85] 毛建华, 黄秋花, 刘萍, 罗成, 奚晓东. BCR-ABL与泛素E3连接酶c-CBL的相互作用在慢性髓系白血病靶向治疗中的作用及相关机制研究. 中国实验血液学杂志[J]. 2017, 25(1): 42-, http://lib.cqvip.com/Qikan/Article/Detail?id=671463609.
[86] Liu, Shien, Hu, Junchi, Zhang, Hao, Xu, Pan, Wan, Wei, Zheng, Mingyue, Yu, Kunqian, Ding, Hong, Jiang, Hualiang, Zhou, Lu, Luo, Cheng. Conformation and dynamics of the C-terminal region in human phosphoglycerate mutase 1. ACTA PHARMACOLOGICA SINICA[J]. 2017, 38(12): 1673-1682, http://dx.doi.org/10.1038/aps.2017.37.
[87] Jiang, Hao, Xing, Jing, Wang, Chen, Zhang, Hao, Yue, Liyan, Wan, Xiaozhe, Chen, Wei, Ding, Hong, Xie, Yiqian, Tao, Hongru, Chen, Zhifeng, Jiang, Hualiang, Chen, Kaixian, Chen, Shijie, Zheng, Mingyue, Zhang, Yuanyuan, Luo, Cheng. Discovery of novel BET inhibitors by drug repurposing of nitroxoline and its analogues. ORGANIC & BIOMOLECULAR CHEMISTRY[J]. 2017, 15(44): 9352-9361, https://www.webofscience.com/wos/woscc/full-record/WOS:000415342200011.
[88] Sun, Zhongya, Zhang, Hao, Chen, Zhifeng, Xie, Yiqian, Jiang, Hao, Chen, Limin, Ding, Hong, Zhang, Yuanyuan, Jiang, Hualiang, Zheng, Mingyue, Luo, Cheng. Discovery of novel BRD4 inhibitors by high-throughput screening, crystallography, and cell-based assays. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS[J]. 2017, 27(9): 2003-2009, http://dx.doi.org/10.1016/j.bmcl.2017.03.012.
[89] Pan, Huiqin, Yang, Wenzhi, Zhao, Dan, Luo, Cheng, Yao, Changliang, Shi, Xiaojian, Zhang, Yibei, Li, Shiyou, Bi, Ying, Wang, Zhen, Yao, Shuai, Wu, Wanying, Guo, Dean. New monoterpenoid oxindole alkaloid derivatives from the stems of Uncaria hirsuta Havil. and their cytotoxicity and tandem mass spectrometric fragmentation. FITOTERAPIA[J]. 2017, 116: 85-92, https://www.webofscience.com/wos/woscc/full-record/WOS:000392779200013.
[90] Wang, Yulan, Li, Linjuan, Zhang, Bidong, Xing, Jing, Chen, Shijie, Wan, Wei, Song, Yakai, Jiang, Hao, Jiang, Hualiang, Luo, Cheng, Zheng, Mingyue. Discovery of Novel Disruptor of Silencing Telomeric 1-Like (DOTI L) Inhibitors using a Target-Specific Scoring Function for the (S)-Adenosyl-L-methionine (SAM)-Dependent Methyltransferase Family. JOURNAL OF MEDICINAL CHEMISTRY[J]. 2017, 60(5): 2026-2036, http://dx.doi.org/10.1021/acs.jmedchem.6b01785.
[91] Mao, Ruifeng, Shao, Jingwei, Zhu, Kongkai, Zhang, Yuanyuan, Ding, Hong, Zhang, Chenhua, Shi, Zhe, Jiang, Hualiang, Sun, Dequn, Duan, Wenhu, Luo, Cheng. Potent, Selective, and Cell Active Protein Arginine Methyltransferase 5 (PRMT5) Inhibitor Developed by Structure-Based Virtual Screening and Hit Optimization. JOURNAL OF MEDICINAL CHEMISTRY[J]. 2017, 60(14): 6289-6304, http://dx.doi.org/10.1021/acs.jmedchem.7b00587.
[92] Zhang, Weiyao, Lu, Wenchao, Jiang, Hao, Lv, Zhengbing, Xie, Yiqian, Lian, Fulin, Liang, Zhongjie, Jiang, Yuxi, Wang, Dajin, Luo, Cheng, Jin, Jia, Ye, Fei. Discovery of alkyl bis(oxy)dibenzimidamide derivatives as novel protein arginine methyltransferase 1 (PRMT1) inhibitors. CHEMICAL BIOLOGY & DRUG DESIGN[J]. 2017, 90(6): 1260-1270, https://www.webofscience.com/wos/woscc/full-record/WOS:000415354300021.
[93] Chen, Zhifeng, Zhang, Hao, Liu, Shien, Xie, Yiqian, Jiang, Hao, Lu, Wenchao, Xu, Heng, Yue, Liyan, Zhang, Yuanyuan, Ding, Hong, Zheng, Mingyue, Yu, Kunqian, Chen, Kaixian, Jiang, Hualiang, Luo, Cheng. Discovery of novel trimethoxy-ring BRD4 bromodomain inhibitors: AlphaScreen assay, crystallography and cell-based assay. MEDCHEMCOMM[J]. 2017, 8(6): 1322-1331, http://dx.doi.org/10.1039/c7md00083a.
[94] 胡骏驰, 徐盼, 陈彦韬, 刘婷婷, 陆冬, 徐圆, 阳怀宇, 罗小民, 朱维良, 郑明月, 于坤千, 罗成, 蒋华良. 科研信息化助力合理药物设计新发展. 中国科学院院刊[J]. 2016, 31(6): 624-, https://kns.cnki.net/KCMS/detail/detail.aspx?dbcode=CJFQ&dbname=CJFDLAST2016&filename=KYYX201606006&v=MzEyNTJGeW5oVnJ2SUxqVFNkckc0SDlmTXFZOUZZb1I4ZVgxTHV4WVM3RGgxVDNxVHJXTTFGckNVUjdxZmIrWm0=.
[95] 刘世恩, 卢俊彦, 蒋华良, 周璐, 罗成. PGAM1的C端构象变化及功能的计算研究. 2016, 147-, https://kns.cnki.net/KCMS/detail/detail.aspx?dbcode=CPFD&dbname=CPFDLAST2017&filename=ZGHY201607036140&v=MTA0MjBIaW50VTc3TUkxNFVQeXJEZDdHNEg5Zk1xSTlHWXVvTERCTkt1aGRobmo5OFRuanFxeGRFZU1PVUtyaWZaZVp2.
[96] Wu, Yunlong, Hu, Junchi, Ding, Hong, Chen, Limin, Zhang, Yuanyuan, Liu, Rongfeng, Xu, Pan, Du, Daohai, Lu, Wenchao, Liu, Jingqiu, Liu, Yan, Liu, YuChih, Lu, Junyan, Zhang, Jin, Yao, Zhiyi, Luo, Cheng. Identification of novel EZH2 inhibitors through pharmacophore-based virtual screening and biological assays. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS[J]. 2016, 26(15): 3813-3817, http://dx.doi.org/10.1016/j.bmcl.2016.05.018.
[97] Ni, Tengfeng, Ye, Fei, Liu, Xing, Zhang, Jie, Liu, Hongchuan, Li, Jiahui, Zhang, Yingyi, Sun, Yinqiang, Wang, Meining, Luo, Cheng, Jiang, Hualiang, Lan, Lefu, Gan, Jianhua, Zhang, Ao, Zhou, Hu, Yang, CaiGuang. Characterization of Gain-of-Function Mutant Provides New Insights into ClpP Structure. ACS CHEMICAL BIOLOGY[J]. 2016, 11(7): 1964-1972, http://www.corc.org.cn/handle/1471x/2374513.
[98] Ye, Fei, Zhang, Weiyao, Lu, Wenchao, Xie, Yiqian, Jiang, Hao, Jin, Jia, Luo, Cheng. Identification of Novel Inhibitors against Coactivator Associated Arginine Methyltransferase 1 Based on Virtual Screening and Biological Assays. BIOMED RESEARCH INTERNATIONAL[J]. 2016, 2016: https://doaj.org/article/195ebcc7514c4fafbba63c5df5b06741.
[99] Yan, Wei, Wang, Xinyi, Dai, Yang, Zhao, Bin, Yang, Xinying, Fan, Jun, Gao, Yinglei, Meng, Fanwang, Wang, Yuming, Luo, Cheng, Ai, Jing, Geng, Meiyu, Duan, Wenhu. Discovery of 3-(5 '-Substituted)-Benzimidazole-5-(1-(3,5-dichloropyridin-4-yl)ethoxy)-1H-indazoles as Potent Fibroblast Growth Factor Receptor Inhibitors: Design, Synthesis, and Biological Evaluation. JOURNAL OF MEDICINAL CHEMISTRY[J]. 2016, 59(14): 6690-6708, http://www.corc.org.cn/handle/1471x/2375122.
[100] Yue, Liyan, Du, Juanjuan, Ye, Fei, Chen, Zhifeng, Li, Lianchun, Lian, Fulin, Zhang, Bidong, Zhang, Yuanyuan, Jiang, Hualiang, Chen, Kaixian, Li, Yuanchao, Zhou, Bing, Zhang, Naixia, Yang, Yaxi, Luo, Cheng. Identification of novel small-molecule inhibitors targeting menin-MLL interaction, repurposing the antidiarrheal loperamide. ORGANIC & BIOMOLECULAR CHEMISTRY[J]. 2016, 14(36): 8503-8519, https://www.webofscience.com/wos/woscc/full-record/WOS:000384313100013.
[101] 张豪, 蒋华良, 罗成. 理论模拟与创新药物发现及蛋白质动态调控研究. 2016, 210-, https://kns.cnki.net/KCMS/detail/detail.aspx?dbcode=CPFD&dbname=CPFDLAST2017&filename=ZGHY201607037186&v=MTQ5MjE5Zk1xSTlHWStvSENoTkt1aGRobmo5OFRuanFxeGRFZU1PVUtyaWZaZVp2SGludFU3N01JMXdkUHlyRGQ3RzRI.
[102] Xu, Yuan, Yue, Liyan, Wang, Yulan, Xing, Jin, Chen, Zhifeng, Shi, Zhe, Liu, Rongfeng, Liu, YuChih, Luo, Xiaomin, Jiang, Hualiang, Chen, Kaixian, Luo, Cheng, Zheng, Mingyue. Discovery of Novel Inhibitors Targeting the Menin-Mixed Lineage Leukemia Interface Using Pharmacophore- and Docking-Based Virtual Screening. JOURNAL OF CHEMICAL INFORMATION AND MODELING[J]. 2016, 56(9): 1847-1855, http://www.corc.org.cn/handle/1471x/2375034.
[103] Zhou Pengfei, Liu Yan, Zhou Lu, Zhu Kongkai, Feng Kechang, Zhang Hao, Liang Yuru, Jiang Hualiang, Luo Cheng, Liu Mingming, Wang Yang. Potent Antitumor Activities and Structure Basis of the Chiral β-Lactam Bridged Analogue of Combretastatin A-4 Binding to Tubulin.. JOURNAL OF MEDICINAL CHEMISTRY[J]. 2016, [104] 蒋华良. Small-molecule targeting of E3 ligase adaptor SPOP in kidney cancer. CANCER CELL[J]. 2016, 30(3): 474-484, http://www.corc.org.cn/handle/1471x/2376307.
[105] 卢俊彦, 胡璐璐, 程净东, 王晨, 徐彦辉, 罗成. 阐明tet家族蛋白质底物偏好性机制. 中国细胞生物学学报[J]. 2016, 38(1): 1-, [106] 罗成. A Systematic Study of Colitis-associated Colon Cancer: from Network Modeling to Drug Combinations.. Sci Rep. 2015, [107] Hu, Lulu, Lu, Junyan, Cheng, Jingdong, Rao, Qinhui, Li, Ze, Hou, Haifeng, Lou, Zhiyong, Zhang, Lei, Li, Wei, Gong, Wei, Liu, Mengjie, Sun, Chang, Yin, Xiaotong, Li, Jie, Tan, Xiangshi, Wang, Pengcheng, Wang, Yinsheng, Fang, Dong, Cui, Qiang, Yang, Pengyuan, He, Chuan, Jiang, Hualiang, Luo, Cheng, Xu, Yanhui. Structural insight into substrate preference for TET- mediated oxidation. NATURE[J]. 2015, 527(7576): 118-122, http://ir.ihep.ac.cn/handle/311005/228828.
[108] 罗成. The Inter-domain Linker of eIF4AI Regulates ATP Hydrolysis Coupled Duplex Unwinding. Nucleic Acids Res. 2015, [109] 罗成. Quantum Chemistry Calculation-Guided Structural Optimization of Combretastatin A-4-like Tubulin Polymerization Inhibitors: Improved Stability and Biological Activity. J Med Chem. 2015, [110] 罗成. Inhibition of human copper trafficking significantly attenuates tumor growth.. Nature Chem. 2015, [111] Kong, Xiangqian, Liu, Jian, Li, Lianchun, Yue, Liyan, Zhang, Lihong, Jiang, Hualiang, Xie, Xin, Luo, Cheng. Functional interplay between the RK motif and linker segment dictates Oct4-DNA recognition. NUCLEIC ACIDS RESEARCH[J]. 2015, 43(9): 4381-4392, http://dx.doi.org/10.1093/nar/gkv323.
[112] Huang, Yue, Yan, Jingli, Li, Qi, Li, Jiafei, Gong, Shouzhe, Zhou, Hu, Gan, Jianhua, Jiang, Hualiang, Jia, GuiFang, Luo, Cheng, Yang, CaiGuang. Meclofenamic acid selectively inhibits FTO demethylation of m(6)A over ALKBH5. NUCLEIC ACIDS RESEARCH[J]. 2015, 43(1): 373-384, https://www.webofscience.com/wos/woscc/full-record/WOS:000350207100037.
[113] 罗成. Selective and irreversible inhibition of pyruvate dehydrogenase kinases by covalently targeting a cysteine residue.. 2015, [114] Meng, Fanwang, Cheng, Sufang, Ding, Hong, Liu, Shien, Liu, Yan, Zhu, Kongkai, Chen, Shijie, Lu, Junyan, Xie, Yiqian, Li, Linjuan, Liu, Rongfeng, Shi, Zhe, Zhou, Yu, Liu, YuChih, Zheng, Mingyue, Jiang, Hualiang, Lu, Wencong, Liu, Hong, Luo, Cheng. Discovery and Optimization of Novel, Selective Histone Methyltransferase SET7 Inhibitors by Pharmacophore- and Docking-Based Virtual Screening. JOURNAL OF MEDICINAL CHEMISTRY[J]. 2015, 58(20): 8166-8181, http://www.corc.org.cn/handle/1471x/2266780.
[115] Zhang, Jie, Liu, Hongchuan, Zhu, Kongkai, Gong, Shouzhe, Dramsi, Shaynoor, Wang, YaTing, Li, Jiafei, Chen, Feifei, Zhang, Ruihan, Zhou, Lu, Lan, Lefu, Jiang, Hualiang, Schneewind, Olaf, Luo, Cheng, Yang, CaiGuang. Antiinfective therapy with a small molecule inhibitor of Staphylococcus aureus sortase. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA[J]. 2014, 111(37): 13517-13522, http://dx.doi.org/10.1073/pnas.1408601111.
[116] Chen, Shijie, Wang, Yulan, Zhou, Wen, Li, Shanshan, Peng, Jianlong, Shi, Zhe, Hu, Junchi, Liu, YuChih, Ding, Hong, Lin, Yijyun, Li, Linjuan, Cheng, Sufang, Liu, Jingqiu, Lu, Tao, Jiang, Hualiang, Liu, Bo, Zheng, Mingyue, Luo, Cheng. Identifying Novel Selective Non-Nucleoside DNA Methyltransferase 1 Inhibitors through Docking-Based Virtual Screening. JOURNAL OF MEDICINAL CHEMISTRY[J]. 2014, 57(21): 9028-9041, https://www.webofscience.com/wos/woscc/full-record/WOS:000344977400025.
[117] Kong, Xiangqian, Chen, Limin, Jiao, Lianying, Jiang, Xiangrui, Lian, Fulin, Lu, Junyan, Zhu, Kongkai, Du, Daohai, Liu, Jingqiu, Ding, Hong, Zhang, Naixia, Shen, Jingshan, Zheng, Mingyue, Chen, Kaixian, Liu, Xin, Jiang, Hualiang, Luo, Cheng. Astemizole Arrests the Proliferation of Cancer Cells by Disrupting the EZH2-EED Interaction of Polycomb Repressive Complex 2. JOURNAL OF MEDICINAL CHEMISTRY[J]. 2014, 57(22): 9512-9521, https://www.webofscience.com/wos/woscc/full-record/WOS:000345722200021.
[118] 罗成. Molecular Dynamic Simulation-driven Design of Protease-responsive Probe for in vivo Tumor Imaging.. Adv Mater. 2014, [119] 张鑫磊, 刘雪英, 张生勇, 孔祥谦, 叶飞, 罗成. dna和组蛋白表观遗传修饰与糖尿病和肥胖的关系以及小分子抑制剂的研究进展. 中国药物化学杂志[J]. 2013, 23(2): 148-, http://lib.cqvip.com/Qikan/Article/Detail?id=45496013.
[120] Li, Juan, Sun, Hua, Jin, Lu, Cao, Wei, Zhang, Jin, Guo, ChongYi, Ding, Ke, Luo, Cheng, Ye, WenCai, Jiang, RenWang. Alleviation of Podophyllotoxin Toxicity Using Coexisting Flavonoids from Dysosma versipellis. PLOS ONE[J]. 2013, 8(8): http://dx.doi.org/10.1371/journal.pone.0072099.
[121] Zhang, Ruihan, Lu, Junyan, Kong, Xiangqian, Jin, Lu, Luo, Cheng. Targeting Epigenetics in Nervous System Disease. CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS[J]. 2013, 12(1): 126-141, https://www.webofscience.com/wos/woscc/full-record/WOS:000315996300018.
[122] Zhang, Hue, Zhang, ChuanRui, Zhu, KongKai, Gao, AnHui, Luo, Cheng, Li, Jia, Yue, JianMin. Fluevirosines A-C: A Biogenesis Inspired Example in the Discovery of New Bioactive Scaffolds from Flueggea virosa. ORGANIC LETTERS[J]. 2013, 15(1): 120-123, http://dx.doi.org/10.1021/ol303146a.
[123] Lu, Junyan, Kong, Xiangqian, Luo, Cheng, Li, Keqin Kathy. Application of Epigenome-Modifying Small Molecules in Induced Pluripotent Stem Cells. MEDICINAL RESEARCH REVIEWSnull. 2013, 33(4): 790-822, https://www.webofscience.com/wos/woscc/full-record/WOS:000319988700003.
[124] Zhu Kongkai, Lu Junyan, Ye Fei, Jin Lu, Kong Xiangqian, Liang Zhongjie, Chen Yong, Yu Kunqian, Jiang Hualiang, Li JunQian, Luo Cheng. Structure-based computational study of the hydrolysis of New Delhi metallo-β-lactmase-1.. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS. 2013, [125] Kongkai Zhu, Junyan Lu, Zhongjie Liang, Xiangqian Kong, Fei Ye, Lu Jin, Heji Geng, Yong Chen, Mingyue Zheng, Hualiang Jiang, JunQian Li, Cheng Luo. A quantum mechanics/molecular mechanics study on the hydrolysis mechanism of New Delhi metallo-β-lactamase-1. JOURNAL OF COMPUTE. 2013, 27(3): http://kns.cnki.net/KCMS/detail/detail.aspx?QueryID=0&CurRec=2&recid=&FileName=SSJD130502010501&DbName=SSJD_01&DbCode=SSJD&yx=&pr=&URLID=&bsm=.
[126] 孔祥谦, 陈丽敏, Cheryl Mccullough, 蒋华良, Ronen Marmorstein, 罗成. 组蛋白乙酰转移酶hMOF小分子抑制剂的发现及应用研究. 2013, 207-, https://kns.cnki.net/KCMS/detail/detail.aspx?dbcode=CPFD&dbname=CPFD0914&filename=ZGHY201309001170&v=MzIwNTF2SGludFU3ekpJRjBSUHlyRGQ3RzRIOUxNcG85Rlplb0lEQk5LdWhkaG5qOThUbmpxcXhkRWVNT1VLcmlmWmVa.
[127] 罗成. Conformational Transition and Energy Landscape of ErbB4 Activated by Neuregulin1β: One-microsecond Molecular Dynamics Simulation. Journal of American Chemistry Society. 2012, [128] Junfeng Jiang, Junyan Lu, Dan Lu, Zhongjie Liang, Lianchun Li, Sisheng Ouyang, Xiangqian Kong, Hualiang Jiang, Bairong Shen, Cheng Luo. Investigation of the Acetylation Mechanism by GCN5 Histone Acetyltransferase. PLOS ONE[J]. 2012, 7(5): https://doaj.org/article/fe4bf522592943288c571517a209ae44.
[129] Li, Keqin Kathy, Luo, Cheng, Wang, Dongxia, Jiang, Hualiang, Zheng, Y George. Chemical and biochemical approaches in the study of histone methylation and demethylation. MEDICINAL RESEARCH REVIEWSnull. 2012, 32(4): 815-867, https://www.webofscience.com/wos/woscc/full-record/WOS:000306140000006.
[130] Tian, JunMian, OuYang, SiSheng, Zhang, Xu, Di, YingTong, Jiang, HuaLiang, Li, HongLin, Dai, WeiXing, Chen, KeYu, Liu, MaiLi, Hao, XiaoJiang, Shen, YunHeng, Luo, Cheng, Zhang, WeiDong. Experimental and computational insights into the conformations of tunicyclin E, a new cycloheptapeptide from Psammosilene tunicoides. RSC ADVANCES[J]. 2012, 2(3): 1126-1135, http://dx.doi.org/10.1039/c1ra00593f.
[131] 罗成. Development of a novel class of B-RafV600E -selective inhibitors through integrated ligand- and structure-based virtual screening. Organic Biomolecular Chemistry. 2012, [132] Zhang, Dengyou, Ai, Jing, Liang, Zhongjie, Li, Chunpu, Peng, Xia, Ji, YinChun, Jiang, Hualiang, Geng, Meiyu, Luo, Cheng, Liu, Hong. Discovery of novel 2-aminopyridine-3-carboxamides as c-Met kinase inhibitors. BIOORGANIC & MEDICINAL CHEMISTRY[J]. 2012, 20(17): 5169-5180, http://dx.doi.org/10.1016/j.bmc.2012.07.007.
[133] Wang, Juxian, Chen, Limin, Sinha, Sarmistha Halder, Liang, Zhongjie, Chai, Huifang, Muniyan, Sakthivel, Chou, YuWei, Yang, Chao, Yan, Leilei, Feng, You, Li, Keqin Kathy, Lin, MingFong, Jiang, Hualiang, Zheng, Yujun George, Luo, Cheng. Pharmacophore-Based Virtual Screening and Biological Evaluation of Small Molecule Inhibitors for Protein Arginine Methylation. JOURNAL OF MEDICINAL CHEMISTRY[J]. 2012, 55(18): 7978-7987, https://www.webofscience.com/wos/woscc/full-record/WOS:000309153500004.
[134] OuYang, Sisheng, Lu, Junyan, Kong, Xiangqian, Liang, Zhongjie, Luo, Cheng, Jiang, Hualiang. Computational drug discovery. ACTA PHARMACOLOGICA SINICA[J]. 2012, 33(9): 1131-1140, http://lib.cqvip.com/Qikan/Article/Detail?id=43191421.
[135] Shen, Qiancheng, Zheng, Mingyue, Lu, Jing, Luo, Cheng, Zhu, Weiliang, Chen, Kaixian, Luo, Xiaomin, Jiang, Hualiang. SOMEViz: A Web Service for Site of Metabolism Estimating and Visualizing. PROTEIN AND PEPTIDE LETTERS[J]. 2012, 19(9): 905-909, https://www.webofscience.com/wos/woscc/full-record/WOS:000307943500001.
[136] Chen, Baoen, Ye, Fei, Yu, Lu, Jia, Guifang, Huang, Xiaotian, Zhang, Xueju, Peng, Shuying, Chen, Kai, Wang, Meining, Gong, Shouze, Zhang, Ruihan, Yin, Jinya, Li, Haiyan, Yang, Yiming, Liu, Hong, Zhang, Jiwen, Zhang, Haiyan, Zhang, Ao, Jiang, Hualiang, Luo, Cheng, Yang, CaiGuang. Development of Cell-Active N-6-Methyladenosine RNA Demethylase FTO Inhibitor. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY[J]. 2012, 134(43): 17963-17971, https://www.webofscience.com/wos/woscc/full-record/WOS:000310483500025.
[137] Wang, YongXiang, Luo, Cheng, Zhao, Dan, Beck, Juergen, Nassal, Michael. Extensive Mutagenesis of the Conserved Box E Motif in Duck Hepatitis B Virus P Protein Reveals Multiple Functions in Replication and a Common Structure with the Primer Grip in HIV-1 Reverse Transcriptase. JOURNAL OF VIROLOGY[J]. 2012, 86(12): 6394-6407, https://www.webofscience.com/wos/woscc/full-record/WOS:000304894100002.
[138] Liang, Zhongjie, Ding, Xiao, Ai, Jing, Kong, Xiangqian, Chen, Limin, Chen, Liang, Luo, Cheng, Geng, Meiyu, Liu, Hong, Chen, Kaixian, Jiang, Hualiang. Discovering potent inhibitors against c-Met kinase: molecular design, organic synthesis and bioassay. ORGANIC & BIOMOLECULAR CHEMISTRY[J]. 2012, 10(2): 421-430, https://www.webofscience.com/wos/woscc/full-record/WOS:000298555700031.
[139] Chen, Liang, Kong, Xiangqian, Liang, Zhongjie, Ye, Fei, Yu, Kunqian, Dai, Weiyi, Wu, Daocheng, Luo, Cheng, Jiang, Hualiang. Theoretical Study of the Mechanism of Proton Transfer in the Esterase Estb from Burkholderia Gladioli. JOURNAL OF PHYSICAL CHEMISTRY B[J]. 2011, 115(44): 13019-13025, https://www.webofscience.com/wos/woscc/full-record/WOS:000296394100040.
[140] Chai, Huifang, Liang, Xinxia, Li, Lin, Zhao, Chunshen, Gong, Ping, Liang, Zhongjie, Zhu, Weiliang, Jiang, Hualiang, Luo, Cheng. Identification of novel 5-hydroxy-1H-indole-3-carboxylates with anti-HBV activities based on 3D QSAR studies. JOURNAL OF MOLECULAR MODELING[J]. 2011, 17(8): 1831-1840, https://www.webofscience.com/wos/woscc/full-record/WOS:000293137800001.
[141] Kong, Xiangqian, Ouyang, Sisheng, Liang, Zhongjie, Lu, Junyan, Chen, Liang, Shen, Bairong, Li, Donghai, Zheng, Mingyue, Li, Keqin Kathy, Luo, Cheng, Jiang, Hualiang. Catalytic Mechanism Investigation of Lysine-Specific Demethylase 1 (LSD1): A Computational Study. PLOS ONE[J]. 2011, 6(9): https://doaj.org/article/edca8149b21d45d0886e2409c57ed3eb.
[142] 陈凯先, 罗小民, 朱维良, 罗成, 蒋华良. 创新药物的模型化和模拟化研究策略. 2011, 2116-2117, https://kns.cnki.net/KCMS/detail/detail.aspx?dbcode=CPFD&dbname=CPFD0914&filename=YYWS201111002313&v=MTg2MDllWnZIaW50VTd2SklsMGNQRFRjZmJHNEg5RE5ybzlGWnVnT0R4Tkt1aGRobmo5OFRuanFxeGRFZU1PVUtyaWZa.
[143] Liang, Zhongjie, Zhang, Liying, Li, Lianchun, Liu, Jun, Li, Hongling, Zhang, Luyong, Chen, Limin, Cheng, Keguang, Zheng, Mingyue, Wen, Xiaoan, Zhang, Pu, Hao, Jia, Gong, Yanchun, Zhang, Xia, Zhu, Xiaoyun, Chen, Jun, Liu, Hong, Jiang, Hualiang, Luo, Cheng, Sun, Hongbin. Identification of pentacyclic triterpenes derivatives as potent inhibitors against glycogen phosphorylase based on 3D-QSAR studies. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY[J]. 2011, 46(6): 2011-2021, http://dx.doi.org/10.1016/j.ejmech.2011.02.053.
[144] 罗成. Identification of N`-(2-oxoindolin-3-ylidene) hydrazide derivatives as c-Met Kinase Inhibitors. Bioorganic Medicinal Chemistry Letter. 2011, [145] 罗成. Structural Switchings Of Staphylococcus Aureus ClpP: A Key To Understanding Protease Mechanism. Journal of Biological Chemistry. 2011, [146] Liang, Zhongjie, Li, Lianchun, Wang, Yuanyuan, Chen, Limin, Kong, Xiangqian, Hong, Yao, Lan, Lefu, Zheng, Mingyue, Cai GuangYang, Liu, Hong, Shen, Xu, Luo, Cheng, Li, Keqin Kathy, Chen, Kaixian, Jiang, Hualiang. Molecular Basis of NDM-1, a New Antibiotic Resistance Determinant. PLOS ONE[J]. 2011, 6(8): https://doaj.org/article/dba05d50fff34165a1c92be4ae43a8bc.
[147] 叶飞, 孔祥谦, 罗成. 鞘氨醇磷酸酯调控机制的研究进展. 中国科学基金[J]. 2010, 279-, http://lib.cqvip.com/Qikan/Article/Detail?id=35183696.
[148] 杜芸, 阳怀宇, 张健, 罗成, 朱维良, 蒋华良. ErbB4激活过程的分子动力学研究. 2010, 83-, https://kns.cnki.net/KCMS/detail/detail.aspx?dbcode=CPFD&dbname=CPFD0914&filename=ZGHY201006016079&v=MTQyODJITXFZOUVZdXNJQlJOS3VoZGhuajk4VG5qcXF4ZEVlTU9VS3JpZlplWnZIaW50VTdyTEtWNFJQeXJEZDdHNEg5.
[149] Liu, Xiaofeng, Xie, Hua, Luo, Cheng, Tong, Linjiang, Wang, Yi, Peng, Ting, Ding, Jian, Jiang, Hualiang, Li, Honglin. Discovery and SAR of Thiazolidine-2,4-dione Analogues as Insulin-like Growth Factor-1 Receptor (IGF-1R) Inhibitors via Hierarchical Virtual Screening. JOURNAL OF MEDICINAL CHEMISTRY[J]. 2010, 53(6): 2661-2665, https://www.webofscience.com/wos/woscc/full-record/WOS:000275711000033.
[150] Qin, Guangrong, Yu, Kunqian, Shi, Ting, Luo, Cheng, Li, Guohui, Zhu, Weiliang, Jiang, Hualiang. How Does Influenza Virus A Escape from Amantadine?. JOURNAL OF PHYSICAL CHEMISTRY B[J]. 2010, 114(25): 8487-8493, http://159.226.238.44/handle/321008/141972.
[151] 罗成. Advance In the Study of Mechanisms regulatd by Sphingosine-1-Phosphate. Bulletin of National Natural Science Foundation of China. 2010, [152] 罗成. 鞘氨磷酸脂调控机制的研究进展. 中国科学基金. 2010, [153] 罗成. Discovery of specific inhibitors against EBNA1 via high throughput in silico virtual screening. PLOS ONE. 2010, [154] Liang, Zhongjie, Shi, Ting, Ouyang, Sisheng, Li, Honglin, Yu, Kunqian, Zhu, Weiliang, Luo, Cheng, Jiang, Hualiang. Investigation of the Catalytic Mechanism of Sir2 Enzyme with QM/MM Approach: SN1 vs SN2?. JOURNAL OF PHYSICAL CHEMISTRY B[J]. 2010, 114(36): 11927-11933, http://ir.simm.ac.cn/handle/153631/1969.
[155] 梁中洁, 石婷, 朱维良, 罗成, 蒋华良. 沉默调控因子SIR2酶催化反应机制的理论研究. 2010, 84-, https://kns.cnki.net/KCMS/detail/detail.aspx?dbcode=CPFD&dbname=CPFD0914&filename=ZGHY201006016080&v=MDM4ODJPVUtyaWZaZVp2SGludFU3ckxKbDRjUHlyRGQ3RzRIOUhNcVk5RVl1c0hEQk5LdWhkaG5qOThUbmpxcXhkRWVN.
[156] 罗成. Development of drugs for Epstein-Barr virus using highthroughput in silico screening. Expert Opinion on Drug Discovery. 2010, [157] 罗成. Why Tamiflu and Zanamivir works on Influenza A (H1N1). Cell Research. 2009, [158] 张超, 杨娜, 杨春皓, 丁华胜, 罗成, 张余, 吴茂江, 章雄文, 沈旭, 蒋华良, 蒙凌华, 丁健. 同时靶向PI3K/mTOR和微管的双重抑制剂的S9抗肿瘤作用. 2009, 220-, https://kns.cnki.net/KCMS/detail/detail.aspx?dbcode=CPFD&dbname=CPFD0914&filename=ZGYS200904001199&v=MDA5NzQ5Rlplb0dCUk5LdWhkaG5qOThUbmpxcXhkRWVNT1VLcmlmWmVadkhpbnRVN3ZOSlY4UlB5clNmYkc0SHRqTXE0.
[159] Hong, Manqing, Fitzgerald, Mary X, Harper, Sandy, Luo, Cheng, Speicher, David W, Marmorstein, Ronen. Structural basis for dimerization in DNA recognition by Gal4. STRUCTURE[J]. 2008, 16(7): 1019-1026, http://dx.doi.org/10.1016/j.str.2008.03.015.
[160] Luo, Cheng, Xie, Peng, Marmorstein, Ronen. Identification of BRAF inhibitors through in silico screening. JOURNAL OF MEDICINAL CHEMISTRY[J]. 2008, 51(19): 6121-6127, https://www.webofscience.com/wos/woscc/full-record/WOS:000259760500029.
[161] Tang, Yong, Meeth, Katrina, Jiang, Eva, Luo, Cheng, Marmorstein, Ronen. Structure of Vps75 and implications for histone chaperone function. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA[J]. 2008, 105(34): 12206-12211, https://www.webofscience.com/wos/woscc/full-record/WOS:000258905700022.
[162] Zhang, Liang, Liu, Weizhi, Hu, Tiancen, Du, Li, Luo, Cheng, Chen, Kaixian, Shen, Xu, Jiang, Hualiang. Structural basis for catalytic and inhibitory mechanisms of beta-hydroxyacyl-acyl carrier protein dehydratase (FabZ). JOURNAL OF BIOLOGICAL CHEMISTRY[J]. 2008, 283(9): 5370-5379, https://www.webofscience.com/wos/woscc/full-record/WOS:000253426700017.
[163] Zou, Hanjun, Luo, Cheng, Zheng, Suxin, Luo, Xiaomin, Zhu, Weiliang, Chen, Kaixian, Shen, Jianhua, Jiang, Hualiang. Molecular insight into the interaction between IFABP and PA by using MM-PBSA and alanine scanning methods. JOURNAL OF PHYSICAL CHEMISTRY B[J]. 2007, 111(30): 9104-9113, http://ir.simm.ac.cn/handle/153631/1714.
[164] Wang, YongXiang, Xu, Xiang, Luo, Cheng, Ma, ZhangMei, Jiang, HuaLiang, Ding, HanPing, Wen, YuMei. Mutational analysis revealed that conservation of hepatitis B virus reverse transcriptase residue 306 (rtP306) is crucial for encapsidation of pregenomic RNA. FEBS LETTERS[J]. 2007, 581(3): 558-564, http://dx.doi.org/10.1016/j.febslet.2007.01.024.
[165] 罗成. A Putative New Domain Target for Anti-Hepatitis B Virus: Residues Flanking epatitis B Virus Reverse Transcriptase Residue 306 (rtP306). 2007, [166] William C. Ho, Cheng Luo, Kehao Zhao, Xiaomei Chai, Mary X. Fitzgerald, Ronen Marmorstein. High-resolution structure of the p53 core domain: implications for binding small-molecule stabilizing compounds. ACTA CRYSTALLOGRAPHICA SECTION D. 2006, 62: http://kns.cnki.net/KCMS/detail/detail.aspx?QueryID=0&CurRec=2&recid=&FileName=SJUC1760622F71C43948691A5B8D65B56913&DbName=WWMERGEJ03&DbCode=WWME&yx=&pr=&URLID=&bsm=.
[167] Chen, Lili, Li, Jian, Luo, Cheng, Liu, Hong, Xu, Weijun, Chen, Gang, Liew, Oi Wah, Zhu, Weiliang, Puah, Chum Mok, Shen, Xu, Jiang, Hualiang. Binding interaction of quereetin-3-beta-galactoside and its synthetic derivatives with SARS-CoV 3CL(pro): Structure-activity relationship studies reveal salient pharmacophore features. BIOORGANIC & MEDICINAL CHEMISTRY[J]. 2006, 14(24): 8295-8306, https://www.webofscience.com/wos/woscc/full-record/WOS:000242454700013.
[168] Jin, Hongwei, Zheng, Suxin, Wang, Zhanli, Luo, Cheng, Shen, Jianhua, Jiang, Hualiang, Zhang, Liangren, Zhang, Lihe. Structural insights into the effect of isonucleosides on B-DNA duplexes using molecular-dynamics simulations. JOURNAL OF MOLECULAR MODELING[J]. 2006, 12(6): 781-791, http://ir.simm.ac.cn/handle/153631/1488.
[169] 罗成. Computational Analysis of Molecular Basis of 1:1 Interactions of NRG-1b Wild-Type and Variants with ErbB3 and ErbB4. 2005, [170] 罗成. b-Hydroxyacyl-acyl carrier protein dehydratase (FabZ) from Helicobacter pylori: molecular cloning, stability characterization and structural modeling. Biochemical and Biophysical Research Communications. 2005, [171] Luo, C, Luo, HB, Zheng, SX, Gui, CS, Yue, LD, Yu, CY, Sun, T, He, PL, Chen, J, Shen, JH, Luo, XM, Li, YX, Liu, H, Bai, DL, Shen, JK, Yang, YM, Li, FQ, Zuo, JP, Hilgenfeld, R, Pei, G, Chen, KX, Shen, X, Jiang, HL. Nucleocapsid protein of SARS coronavirus tightly binds to human cyclophilin A. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS[J]. 2004, 321(3): 557-565, https://www.webofscience.com/wos/woscc/full-record/WOS:000223277600007.
[172] Shao, D, Zou, CY, Luo, C, Tang, XC, Li, YC. Synthesis and evaluation of tacrine-E2020 hybrids as acetylcholinesterase inhibitors for the treatment of Alzheimer's disease. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS[J]. 2004, 14(18): 4639-4642, http://dx.doi.org/10.1016/j.bmcl.2004.07.005.
[173] Xu, Y, Liu, H, Niu, CY, Luo, C, Luo, XM, Shen, JH, Chen, KX, Jiang, HL. Molecular docking and 3D QSAR studies on 1-amino-2-phenyl-4-(piperidin-1-yl)-butanes based on the structural modeling of human CCR5 receptor. BIOORGANIC & MEDICINAL CHEMISTRY[J]. 2004, 12(23): 6193-6208, http://dx.doi.org/10.1016/j.bmc.2004.08.045.
[174] Chen, G, Luo, XM, Zhu, WL, Luo, C, Liu, H, Puah, CM, Chen, KX, Jiang, HL. Elucidating inhibitory models of the inhibitors of epidermal growth factor receptor by docking and 3D-QSAR. BIOORGANIC & MEDICINAL CHEMISTRY[J]. 2004, 12(9): 2409-2417, http://dx.doi.org/10.1016/j.bmc.2004.02.001.
[175] YUXiao-Jing, LUOCheng, LinJian-Cheng, HAOPei, HEYou-Yu, GUOZong-Ming, QINLei, SUJiong, LIUBo-Shu, HUANGYin, NANPeng, LIChuan-Song, XIONGBin, LUOXiao-Min, ZHAOGuo-Ping, PEIGang, CHENKai-Xian, SHENXu, SHENJian-Hua, ZOUJian-Ping, HEWei-Zhong, SHITie-Liu, ZHONGYang, JIANGHua-Liang, LIYi-Xue. Putative hAPN receptor binding sites in SARS_CoV spike protein. 中国药理学报:英文版[J]. 2003, 24(6): 481-488, http://lib.cqvip.com/Qikan/Article/Detail?id=7970303.
[176] Qin, L, Xiong, B, Luo, C, Guo, ZM, Hao, P, Su, J, Nan, P, Feng, Y, Shi, YX, Yu, XJ, Luo, XM, Chen, KX, Shen, X, Shen, JH, Zou, JP, Zhao, GP, Shi, TL, He, WZ, Zhong, Y, Jiagn, HL, Li, YX. Identification of probable genomic packaging signal sequence from SARS-CoV genome by bioinformatics analysis. ACTA PHARMACOLOGICA SINICA[J]. 2003, 24(6): 489-496, http://lib.cqvip.com/Qikan/Article/Detail?id=7970304.
[177] Xiong, B, Gui, CS, Xu, XY, Luo, C, Chen, J, Luo, HB, Chen, LL, Li, GW, Sun, T, Yu, CY, Yue, LD, Duan, WH, Shen, JK, Qin, L, Shi, TL, Li, YX, Chen, KX, Luo, XM, Shen, X, Shen, JH, Jiang, HL. A 3D model of SARS_CoV 3CL proteinase and its inhibitors design by virtual screening. ACTA PHARMACOLOGICA SINICA[J]. 2003, 24(6): 497-504, http://lib.cqvip.com/Qikan/Article/Detail?id=7970305.
[178] Luo, C, Wang, WN, Qiao, MH, Fan, KN. Adsorption of sulfur on NimB2 clusters: a theoretical investigation on the mechanism of strong sulfur resistance of Ni-B alloy catalyst. JOURNAL OF MOLECULAR CATALYSIS A-CHEMICAL[J]. 2002, 184(1-2): 379-386, http://dx.doi.org/10.1016/S1381-1169(02)00037-7.
[179] Luo, C, Shen, BR, Fan, KN, Deng, JF, Liu, HL. Theoretical study on the local structure and properties of electron transfer of Ni-B amorphous alloy. ACTA CHIMICA SINICA[J]. 2000, 58(8): 948-952, http://ir.sim.ac.cn/handle/331004/95843.

科研活动

   
科研项目
(1) 针对重要疾病的新化学实体发现与优化,主持,国家级,2012-01--2016-12
(2) 针对 S1P 代谢通路和NF-kB 通路的网络节点的动力学行为、靶标发现和非可控炎症转化机制研究,主持,国家级,2011-01--2013-12
(3) 针对调控干细胞相关关键酶的药物发现与作用机制研究,主持,国家级,2011-01--2015-12
(4) 军队特需药品发现技术平台(子课题),主持,国家级,2011-01--2015-12
(5) 基于桑叶活性成分为物质基础的a-糖苷酶抑制剂优化研究(子课题),主持,省级,2011-01--2013-12
(6) 针对嘌呤生物合成的抗金黄色葡萄球药物设计研究,主持,其他级,2010-04--2012-03
(7) 抗肿瘤药物先导化合物的优化研究,主持,国家级,2010-01--2012-12
参与会议
(1) 金黄色葡萄球菌ClpP蛋白酶的功能调控研究,福建—香港高校理论化学研讨会,2011-04,罗成

指导学生

已指导学生

张芮菡  硕士研究生  100720-药物设计学  

周然  硕士研究生  078020-药物设计学  

现指导学生

王晨  硕士研究生  0780Z1-药物设计学  

李晓娜  博士研究生  100706-药理学  

徐盼  硕士研究生  0780Z1-药物设计学  

胡骏驰  博士研究生  1007Z1-药物设计学  

工作经历

   
工作简历
2012-10--今 上海药物研究所 研究员
2008-09--2012-09 中国科学院上海药物研究所 副研究员
2008-03--2008-09 中国科学院上海药物研究所 助理研究员
2004-07--2005-08 中国科学院上海药物研究所 助理研究员
1994-11--1998-04 福州市抗生素集团有限公司 助理工程师